key: cord-0036502-004a6lit authors: Han, Bing-Nan; Hong, Li-Li; Gu, Bin-Bin; Sun, Yang-Ting; Wang, Jie; Liu, Jin-Tang; Lin, Hou-Wen title: Natural Products from Sponges date: 2019-06-08 journal: Symbiotic Microbiomes of Coral Reefs Sponges and Corals DOI: 10.1007/978-94-024-1612-1_15 sha: e5f65e5c8df2bfcda5d3e152feb0afbb476102b3 doc_id: 36502 cord_uid: 004a6lit The sponge is one of the oldest multicellular invertebrates in the world. Marine sponges represent one of the extant metazoans of 700–800 million years. They are classified in four major classes: Calcarea, Demospongiae, Hexactinellida, and Homoscleromorpha. Among them, three genera, namely, Haliclona, Petrosia, and Discodemia have been identified to be the richest source of biologically active compounds. So far, 15,000 species have been described, and among them, more than 6000 species are found in marine and freshwater systems throughout tropical, temperate, and polar regions. More than 5000 different compounds have been isolated and structurally characterized to date, contributing to about 30% of all marine natural products. The chemical diversity of sponge products is high with compounds classified as alkaloids, terpenoids, peptides, polyketides, steroids, and macrolides, which integrate a wide range of biological activities, including antibacterial, anticancer, antifungal, anti-HIV, anti-inflammatory, and antimalarial. There is an open debate whether all natural products isolated from sponges are produced by sponges or are in fact derived from microorganisms that are inhaled though filter-feeding or that live within the sponges. Apart from their origin and chemoecological functions, sponge-derived metabolites are also of considerable interest in drug development. Therefore, development of recombinant microorganisms engineered for efficient production of sponge-derived products is a promising strategy that deserves further attention in future investigations in order to address the limitations regarding sustainable supply of marine drugs. Considering that oceans comprise over 70% of the earth's surface and harbor a tremendous variety of flora and fauna, marine habitat represents an unexplored source of new bioactive molecules. Although still quite young by many standards, since the 1950s, this field of marine natural products has undergone exponential growth and proven to be a productive source for structurally diverse secondary metabolites. Due to long evolutionary processes favoring the accumulation of strongly bioactive compounds, sponges (Porifera) and their associated microorganisms have become the largest contributors of marine natural products. Seemingly primitive and morphologically defenseless organisms like sponges developed ingenious survival strategies which rely heavily on the accumulation of defensive products protecting them from a multitude of stress factors that involve overgrowth by fouling organisms, attacking by predators, and invasion by pathogenic microorganisms. Sponges are classified in four major classes: Calcarea, Demospongiae, Hexactinellida, and Homoscleromorpha. Among them, three genera, namely, Haliclona, Petrosia, and Discodemia have been identified to be the richest source of biologically active compounds. The chemical diversity of sponge products is high with compounds classified as alkaloids, terpenoids, peptides, polyketides, steroids, and macrolides, which integrate a wide range of biological activities, including antibacterial, anticancer, antifungal, anti-HIV, anti-inflammatory, and antimalarial. Biologically significant alkaloids, as a special and important class of bioactive natural products, are widely distributed over terrestrial and marine organisms. Recent studies have demonstrated that marine invertebrates and microorganisms are abundant sources of these secondary metabolites. Among these natural products, imidazole-, oxazole-, and thiazole-containing alkaloids are often found to show diverse significant biological activities, including antitumor, antibacterial, antiviral, antimalarial, immunosuppressive activities, etc. The following review summarizes the latest progress on the isolation, structure identification of a diverse 209 alkaloids from 66 marine sponges with potent biological activities within the literature coverage from 1986 to 2016. In the year of 1993, xestocyclamine A (1) was isolated from Papua New Guinea collections of the sponge Xestospongia sp. Pure xestocyclamine A exhibited an IC 50 = 4 μg/mL (10.1 μM) against PKC є and also exhibits activity in a whole cell IL-1 release assay with an IC 50 of 1 μM [1] . In the year of 1994, madangamine A (2) was isolated from the marine sponge Xestospongia ingens, which showed in vitro cytotoxicity against murine leukemia P388 (ED 50 0.93 μg/mL) [2] . In 1996, sceptrine (3) and ageliferine (4) were isolated from Xestospongia sp. and Agelas novaecaledoniae collected at Baic de Prony, exhibiting a high affinity for somatostatin (IC 50 = 0.27 μM and 2.2 μM) [3] . Within the same year, 4,5-dibromopyrrole-2-carbamide (5) was isolated from the marine sponge Agelas mauritiana collected off Hachijo-jima Island, Japan. 4,5-dibromopyrrole-2-carbamide (5) promoted larval metamorphosis of the ascidian Ciona savignyi at a concentration of 2.5 μg/mL (9.36 μM) [4] . (±)-xestospongin D (6) was isolated from the Singapore marine sponge Niphates sp. collected from south of the Beting Bemban Besar reef. (6) was found to inhibit growth of certain human cancer cell lines comprising the NCI panel (leukemia subpanel, mean GI 50 3.62 ± 2.02 μM; breast subpanel, mean GI 50 4.53 ± 1.98 μM) as well as the murine P388 lymphocytic leukemia (ED 50 1.7 μg/mL) (3.67 μM) [5] . In the year of 1998, the chemical investigation of Micronesian sponge Oceanapia sp. from Truk Lagoon, afforded two active pyridoacridine alkaloids: the known compound kuanoniamine D (7) as well as the new N-deacyl derivative of the kuanoniamines (8) . The IC 50 of N-deacyl derivative of the kuanoniamines (8) was 1.2 μg/mL (3.77 μM) against HeLa cells and 2.0 μg/mL against MONO-MAC 6 cells. In receptor binding assays, kuanoniamine D (7) showed potent affinity to A1 adenosine receptors with Ki value of 2.94 μM [6] . In 1999, halitulin (9) was isolated from the sponge Haliclona tulearensis collected in Sodwana Bay, Durban, South Africa. It was found to be cytotoxic against several tumor cell lines: P388, A549, HT29, and MEL28 in concentration of 12-25 ng/mL [7] . Discorhabdin Q (16, 17-dehydrodiscorhabdin B) (10) was isolated from cytotoxic extracts of the sponge Latrunculia purpurea and numerous collections of Zyzzya massalis, Z. fuliginosa, and Z. spp from Australia and Fiji. In the NCI 60-cell line antitumor screen, discorhabdin Q (10) exhibited moderate cytotoxicity (mean panel GI 50 = 0.5 μg/mL) [8] . In the same year, five new steroidal alkaloids, plakinamines C and D (11) , and three related compounds were isolated from the Vanuatu sponge Corticium sp. collected off Porth Havannah, Vanuatu, South Pacific. Two new compounds (12 and 13) performed good in vitro cytotoxicity against human bronchopulmonary non-small-cell lung carcinoma cells (NSCLC-N6) with IC 50 values of 3.3-5.7 μg/mL, while plakinamine D (11) was cytotoxic with IC 50 < 3.3 μg/mL [9] . In 2000, topsentins B1 (14) was isolated from the marine sponge Rhaphisia lacazei, collected in the Mediterranean Sea which showed antiproliferative activity against human bronchopulmonary cancer cells with an IC 50 of 6.3 μg/mL [10] . Dragmacidin F (15) , possessing an unprecedented carbon skeleton, was isolated from a marine sponge of the genus Halicortex collected off the southern coast of Ustica Island (Italy), which showed good in vitro antiviral activity toward HIV-1 (EC 50 = 0.91 μM) [11] . In the year of 2001, makaluvamine P (16) was isolated from the sponge Zyzzya cf. fuliginosa collected in the waters off the Vanuatu Islands. Makaluvamine P (16) was found to inhibit the growth of KB tumor cells with 64% on at 3.2 μg/mL (9.5 μM) [12] . In 2002, the sponge Stylissa massa collected from the shallow waters around Helgoland afforded eight known alkaloids, among which 10 E-hymenialdisine (17) and 10 Z-hymenialdisine (18) were active in the initial Raf/MEK-1/MAPK signaling cascade assay (IC 50 = 3 and 6 nM) [13] . Arenosclerins A-C (19) (20) (21) and haliclonacyclamine E (22) , isolated from the marine sponge Arenosclera brasiliensis, exhibited certain cytotoxity against human HL-60 (leukemia), L929 (fibrosarcoma), B16 (melanoma), and U138 (colon) cancer cell lines at concentrations between 1.5 and 7.0 μg/mL [14] . In addition, isonaamidine E (23) was isolated from two sponges, Leucetta chagosensis and Leucetta cf. chagosensis, collected from the Great Barrier Reef and the Fiji Islands, which was found to be cytotoxic toward several tumor cell lines (GI 50 values was 1.3 μg/mL) [15] . In 2003, manadomanzamines A (24) and B (25) were isolated from an Indonesian sponge Acanthostrongylophora sp. (Haplosclerida: Petrosiidae). Manadomanzamines A (24) and B (25) exhibited strong activity against Mycobacterium tuberculosis (Mtb) with MIC values of 1.9 and 1.5 μg/M (2.4 μΜ) [16] . In 2004, seven pyrrole alkaloids isolated from Agelas sponges were tested for interactions with the cellular calcium homeostasis. Among them, brominated pyrrole alkaloids reduced voltage-dependent calcium elevation in PC12 cells, and dibromosceptrin (26) was the most potent alkaloid with a half maximal of 2.8 μM [17] . (24) Manadomanzamines B (25) In 1994, manzamine A (27) , 8 -hydroxymanzamine A (28) , and 8-methoxymanzamine A (29) were derived from an unidentified sponge, Pachypellina sp. All the compounds showed antitumor and anti-HSV-II activities [18] , and the compounds 27 and 28 also showed potent anti-inflammatory, antifungal, and anti-HIV-1 activities [19] . In 2004, compounds manzamine J (30), 8-hydroxymanzamine J (31) , manzamine A N-oxide (32) , manzamine E (33), 6-hydroxymanzamine E (34) , manzamine F (35) , and ircinol A (36) isolated from a common Indonesian sponge of the genus Acanthostrongylophora showed diverse activities against malaria, mycobacterium tuberculosis, leishmania, HIV-1, and AIDS opportunistic infections [20] . In 2006, a structurally related compound manzamine Y (37) was obtained from the genus Acanthostrongylophora. Compounds 27, 28, 33, 34, 35, and 37 displayed the cytotoxicity against Plasmodium falciparum and Vero cells [21] . Compounds 27, 28, and 33 also showed neuritogenic activity against Neuro-2a cells with IC 50 values of 3.3, 3.2, and 5.7 μM [22] . In 2009, the new analogues zamamidine C (38), 3,4-dihydro-6-hydroxy-10,11-epoxymanzamine A (39) , and 3,4-dihydromanzamine J N-oxide (40) were purified from an Okinawan marine sponge Amphimedon species. All the compounds showed cytotoxicity against the three human tumor cell lines P388 murine leukemia L1210, human epidermoid carcinoma KB cells, and murine leukemia, and compounds 38 and 40 also possessed inhibitory activities against T.b. brucei (IC 50 = 0.27, 4.44, μg/mL, respectively) and P. falciparum (IC 50 = 0.58, 7.02, μg/mL, respectively) in vitro [23] . In the year 2004, three new pyrroloiminoquinone alkaloids, 3-dihydro-7,8dehydrodiscorhabdin C (41), 14-bromo-3-dihydro-7,8-dehydrodiscorhabdin C (45) , discorhabdin V (46) , and three known compounds 14-bromodiscorhabdin C (44), 14-bromo-3-dihydrodiscorhabdin C (42) , and 3-dihydrodiscorhabdin C (43) were yielded from the sponge Tsitsikamma pedunculata with the cytotoxicity activity against human colon tumor (HCT-116) cancer cell line at IC 50 values of 0.197, 0.222, 1.266, 0.077, 0.645, and 0.323 μM, respectively. Then tsitsikammamine A (47) and tsitsikammamine B (48) were isolated from the sponge Tsitsikamma favus with cytotoxicity activity inhibiting against HCT-116 cancer cell line at IC 50 of 1.414 and 2.382 μM. Two new compounds 1-methoxydiscorhabdin D (49) and 1-aminodiscorhabdin D (50) and five known metabolites, damirone B (51), makaluvic acid A (52) , makaluvamine C (53), discorhabdin G (54) , and discorhabdin N (55) , obtained from the sponge Latrunculia bellae exhibited cytotoxic activity against HCT-116 cell line with IC 50 values of 0.232, 0.119, 3.102, 1.089, 0.327, and 2.249 μM, respectively. Discorhabdin A (56) and discorhabdin D (57) isolated from the sponge Strongylodesma algoaensis displayed cytotoxicity activity against HCT-116 cancer cell line which IC 50 values are 0.007 and 0.595 μM, respectively [24] . In 2008, compounds discorhabdin G (54), B (58) , L (59) , and W (60) isolated from Latrunculia species sponges were found cytotoxic toward the P388 murine leukemia cell line with IC 50 values of 0.1-1.08 μM [25] . In 2012, bispyrroloiminoquinone alkaloids, tsitsikammamine C (61) , and makaluvamines J (62), G (63) , and L (64) were obtained from the Australian marine sponge Zyzzya sp. Tsitsikammamine C displayed potent antimalarial activity with IC 50 values of 13 and 18 nM against chloroquine-sensitive (3D7) and chloroquine-resistant (Dd2) Plasmodium falciparum, respectively. Compounds 62-64 displayed potent growth inhibitory activity (IC 50 < 100 nM) against both P. falciparum lines and only moderate cytotoxicity against HEK293 cells (IC 50 = 1-4 μM) [26] . Fascaplysin (65) isolated from the sponge Thorectandra sp. in 2005 displayed inhibitory activity in the Cdc25B assay with an IC 50 value of 1.0 μg/mL [27] . Compounds (R)-6′′-debromohamacanthin A (66) and cis-3,4-dihydrohamacanthin B (67) isolated from the sponge Spongosorites sp. were cytotoxic against A549 (human lung cancer), SK-OV-3 (human ovarian cancer), SK-MEL-2 (human skin cancer), XF498 (human CNS cancer), and HCT 15 (human colon cancer) cell lines with IC 50 values ranging from 2.83 to 3.85 μg/mL [28] . In 2006, structurally similar compounds deoxytopsentin (68) , hamacanthin A (69) , and hamacanthin B (70) were isolated from the sponge Spongosorites sp., all of which showed antimicrobial activity against various strains of bacteria and fungi, among which deoxytopsentin (68) and hamacanthin A (69) also exhibited significant antibacterial activity against methicillin-resistant Staphylococcus aureus and moderate cytotoxicity against cancer cell lines [29] . Compounds cortistatins A (71), B (72), C (73), and D (74) from the sponge Corticium simplex displayed potent antiproliferative activities against HUVECs which IC 50 values are from 0.0018 to 1.1 μM. The compound 71 also exhibited activities against normal human dermal fibroblast (NHDF), epidermoid carcinoma cells (KB3-1), human chronic myelogenous leukemia cells (K562), and murine neuroblastoma cells (Neuro-2A) with IC 50 values of 6.0, 7.0, 7.0, and 6.0 μM [30] . The marine sponge Dactylia sp. yielded one alkaloid ircinamine B (75) , which was cytotoxic against P388 cell line (IC 50 = 0.28 μM) [31] . In 2007, psammaplysenes C (76) and D (77) were identified from the sponge Psammoclemma sp. as the P2X7 receptor antagonists both for the treatment of inflammatory disease with IC 50 value of 7 μM [32] . Three bis-piperidine alkaloids, haliclonacyclamine F (78) and arenosclerins D (79) and E (80), were isolated from the marine sponge Pachychalina alcaloidifera, which displayed cytotoxic activity against SF295 (human CNS), MDA-MB-435 (human breast), and HL-60 (leukemia) cancer cell lines with IC 50 values ranging from 1.0 to 4.5 μg/mL [33] . In 2010, structurally related compound neopetrosiamine A (81) was isolated from the marine sponge Neopetrosia proxima collected off the west coast of Puerto Rico, which showed inhibitory activity against MALME-3M melanoma cancer, CCRFCEM leukemia, and MCF-7 breast cancer with IC 50 values of 1.5, 2.0, and 3.5 μM, respectively, also showing the antiplasmodial activity against Plasmodium falciparum (IC 50 = 2.3 μM) [34] . The compound haliclonacyclamine A (82) was isolated from the Haliclona sponge Haliclona sp. at Solomon Islands. In vitro assay of haliclonacyclamine A against the chloroquine-sensitive 3D7 and chloroquine-resistant strain P. falciparum FcB1 gave, respectively, IC 50 of 0.33 and 0.052 mg/mL. The cytotoxicity of 82 was measured on breast cancer cells MCF-7 with IC 50 value of 2.6 mg/ mL [35] . 16b-Hydroxycrambescidin 359 (83) , batzelladines L and M (84, 85) , ptilomycalin A (86), crambescidine 800 (87), batzelladine C (88) , and dehydrobatzelladine C (89) were isolated from the Jamaican sponge Monanchora unguifera, all of which exhibited antimalarial activity against Plasmodium falciparum D6 clone and W2 clone with IC 50 values ranging from 73 to 270 ng/mL. Moreover, their activities of antitumor, anti-tuberculosis, HIV-1, antimicrobial and antimalarial were evaluated. Among them, batzelladine L (84) showed the most potent activity against Mycobacterium tuberculosis with a MIC of 1.68 mg/mL, ptilomycalin A (86), and crambescidine 800 (87) In 2008, compounds (+)-aplysinillin (106) and dienone (107) yielded from the marine sponge Aplysinella sp. collected from the Federated States of Micronesia were evaluated for their cancer cell growth inhibition against the MCF-7 cancer cell line with IC 50 values of 1.19 ± 0.10 and 0.89 ± 0.11 μM, respectively [42] . Trachycladindoles A-F (108-113) were yielded from a southern Australian marine sponge, Trachycladus laevispirulifer, and they showed cytotoxicity against lung (A549), colorectal (HT29), and breast (MDA-MB-231) cell lines with GI 50 values ranging from 0.3 to 12.2 μM [43] . In 2009, nagelamides Q (114) and R (115) , isolated from Okinawan marine sponges of the genus Agelas, showed antimicrobial activity against Trichophyton mentagrophytes with MIC values of 6 μg/mL [44] . Benzosceptrin C (116), isolated from an Okinawan marine sponge of the genus Agelas, displayed antimicrobial activity against Micrococcus luteus and Cryptococcus neoformans with MIC values of 6 μg/mL, respectively [45] . In 2010, chemical investigation of the Australian marine sponge Ecionemia geodides found a new pyridoacridine alkaloid, ecionines A (117) along with the previously isolated marine natural product meridine (118) . The compounds exhibited moderate cytotoxicity against a panel of human bladder cancer cell lines, including the increasingly metastatic TSU-Pr1 series (TSU-Pr1, TSU-Pr1-B1, and TSU-Pr1-B2) and the superficial bladder cancer cell line 5637, with IC 50 values ranging from 3 to 7 μM [46] . Bastadin 26 (119) isolated from Australian marine sponge Ianthella flabelliformis showed potent affinity for the guinea pig δ-opioid receptors with IC 50 value of 206 nM and a Ki value of 100 nM [47] . Eleven DOPA-derived pyrrole alkaloids, named baculiferins A-C, E-H, and K-N (120-130), were isolated from the Chinese marine sponge Iotrochota baculifera and found to be potent inhibitors against the HIV-1 IIIB virus in both MT4 and MAGI cell lines with IC 50 values ranging from 0.1 to 8.4 μM [48] . Monanchocidin (131), a guanidine alkaloid with an unprecedented skeleton system possessing cytotoxicity against human leukemia THP-1 with IC 50 value of 5.1 μM, was isolated from the sponge Monanhora pulchra [49] . Two bromotyrosine alkaloids, ceratinadins A and B (132) (133) , were isolated from an Okinawan marine sponge Pseudoceratina sp., and they showed antifungal activity against Cryptococcus neoformans (MIC, 4 and 8 μg/mL, respectively) and Candida albicans (MIC, 2 and 4 μg/mL, respectively) [50] . Psammaplysin F (134) In 2012, 12-N-methyl stevensine (147), Z-hymenialdisine (148) , and Z-debromohymenialdisine (149) were obtained from a collection of Indonesian marine sponge Stylissa species off Derawan Islands, Berau, NE Kalimantan, which showed significant activity against mouse lymphoma cell line L5187Y with EC 50 values of 3.5, 1.8, and 2.1 μg/mL, respectively [57] . Densanins A (150) and B (151) were isolated from the sponge Haliclona densaspicula and displayed relatively potent inhibitory effects on lipopolysaccharide-induced nitric oxide production in BV2 microglial cells with IC 50 values of 1.05 and 2.14 μM, respectively [58] . Ingamine A (152), 22(S)-hydroxyingamine A (153) , and dihydroingenamine D (154) were isolated from marine sponge Petrosid Ng5 Sp5 (family Petrosiidae) obtained from the open repository of the National Cancer Institute, USA. All compounds showed strong antiplasmodial activity against chloroquine-sensitive (D6) and chloroquine-resistant (W2) strains of Plasmodium falciparum with IC 50 values of 57-220 ng/mL. Compounds 152-154 also displayed weak antimicrobial and moderate antileishmanial activities against Leishmania donovani promastigotes [59] . Six halogenated alkaloids named purpuroines A, C-D, and F-H (155) (156) (157) (158) (159) (160) were isolated from the marine sponge Iotrochota purpurea. Bioassay for the regulation of tyrosine kinases revealed compounds 155-160 possessing inhibitory activities against the kinase LCK and PLK1 with IC 50 values ranging from 0.94 to 11.88 μg/mL [60] . Nakijinamines A (161) obtained from an Okinawan marine sponge Suberites sp. exhibited antimicrobial activity against Candida albicans (IC 50 = 0.25 μg/mL), Cryptococcus neoformans (IC 50 = 0.5 μg/mL), Trichophyton mentagrophytes (IC 50 = 0.25 μg/mL), and Micrococcus luteus (MIC 2 μg/mL) [61] . Two alkaloids, (−)-ageloxime D (162) and ageloxime B (163), were isolated from the marine sponge Agelas mauritiana, and both showed activity against Cryptococcus neoformans with IC 50 values of 5.94 and 4.96 μg/mL, respectively. Compound 163 also exhibited antibacterial activity against Staphylococcus aureus (IC 50 = 7.21 μg/ mL) and methicillin-resistant S. aureus (IC 50 = 9.20 μg/mL) [62] . In 2013, thiaplakortones A−D (164) (165) (166) (167) obtained from the Australian marine sponge Plakortis lita displayed significant growth inhibition against chloroquinesensitive (3D7) and chloroquine-resistant (Dd2) Plasmodium falciparum (IC 50 values <651 nM) and only moderate cytotoxicity against HEK293 cells (IC 50 values >3.9 μM). 164 was the most active natural product, with IC 50 values of 51 and 6.6 nM against 3D7 and Dd2 lines, respectively [63] . Calyculin A (168) was isolated from the marine sponge Discodermia calyx collected off Shikine-jima Island, Japan, which exhibited potent cytotoxicity as well as tumor promotion activity, attributed to its strong and specific inhibition of Ser/Thr protein phosphatases 1 (PP1, IC 50 = 1.4 nM) and 2A (PP2A, IC 50 = 2.6 nM) [64] . Two alkaloids, pyrinodemins G and H (169, 170) , were isolated from an Okinawan marine sponge Amphimedon sp., and they showed cytotoxicity against P388 murine leukemia cells (IC 50 9.6 and 2.5 μg/mL, respectively) in vitro [65] . Three dimeric bromopyrrole alkaloids, nagelamides X-Z (171-173), were isolated from a marine sponge Agelas sp., and they exhibited antimicrobial activity with IC 50 values ranging from 2.0 to 8.0 μg/mL [66] . Unique bromopyrrole alkaloids, nagelamides U and W (174, 175) , were isolated from a marine sponge Agelas sp., exhibiting inhibitory activity against Candida albicans (IC 50 4 μg/mL, each) [67] . Spongiacidin C (176) isolated from the marine sponge Stylissa massa inhibited USP7 most strongly with an IC 50 of 3.8 μM among several USP family members tested [68] . N-containing metabolites (177, 178) were isolated from the South China Sea sponge Agelas clathrodes and showed moderate cytotoxicity against cancer cell line SGC7901 [69] . 2-Methoxy-3oxoaaptamine (179), 2,3-dihydro-2,3-dioxoaaptamine (180), demethyl(oxy)aaptamine (181), 3-aminodemethyl(oxy)aaptamine (182) , and 3-(methylamino) demethyl(oxy)aaptamine (183) were isolated from a marine sponge of Aaptos sp., among which 179 was presented antimycobacterial activity against Mycobacterium smegmatis in both active-growing and dormancy-inducing hypoxic conditions with a minimum inhibitory concentration (MIC) of 6.25 μg/ml, and compounds 180-183 showed antimycobacterial activities under hypoxic condition selectively, with MIC values of 1.5-6.25 μg/ml [70] . In 2015, compounds 10-methoxy-2-methylimidazo[4,5,1-ij] pyrido[2,3,4-de] quinolone (184), 3-(phenethylamino) demethyl(oxy)aaptamine (185) , demethyl(oxy) aaptamine (181) , aaptamine (186) , and 3-(methylamino)demethyl(oxy)aaptamine (183) were isolated from the South China Sea sponge Aaptos aaptos, exhibiting cytotoxic activities against HeLa, K562, MCF-7, and U937 cell lines with IC 50 val-ues in the range of 0.90-12.32 μM [71] . Netamines Q (187) isolated from the Madagascar sponge Biemna laboutei exhibited antiplasmodial activities with IC 50 values of 8.37 μM [72] . Indole alkaloids 188, penaresin (189), indolecarbaldehyde (190) , and plakohypaphorine D (191) were isolated from the sponge Plakortis sp. collected from Zampa in Okinawa, all of which showed cytotoxicity against P388 cells with IC 50 values of 0.6, 5, 0.1, and 3.2 μg/mL, respectively [73] . The investigation of South China Sea nudibranch Jorunna funebris and its sponge-prey Xestospongia sp. led to the isolation of fennebricin C (192) , fennebricin D (193) , renieramycin J (194) , fennebricin A (195) , renierone (196) , and N-formyl-1,2dihydrorenierone (197) . All of the compounds showed the inhibitory activities of NF-κB signaling pathway with IC 50 values ranging from 1.0 to 9.7 μM, and fennebricin A (195) also exhibited growth inhibition against both A549 and HL-60 cell lines with IC 50 values of 6.2 and 2.5 μM [74] . Crambescin A2 392 (198) , crambescin A2 406 (199) , crambescin A2 420 (200) , and Scheme 575948 (201) were obtained from the marine sponge Pseudaxinella reticulata collected off the Bahamas. These compounds showed antifungal activity against the human pathogens (208) , and papuamine (209) were isolated from the Okinawan marine sponge Halichondria panicea. These compounds exhibited antimycobacterial activities with inhibition zones of 7-16 mm at 10 μg/disc and also showed apparent activity against the proliferation of the cancer cell line Huh-7 with IC 50 values from 3.6 to 7.8 μM [77] . Marine sponges are shown to have a large variety of resources of bioactive peptides. From the structure, they possess linear peptides, cyclic peptides, and depsipeptides which of them have highly modified structural features of nonproteinogenic amino acid or hydroxy acid group, while others have those with minimal differences from the common ribosomal peptides. This review summarizes the isolation, structure identification of a diverse 109 peptides from 27 marine sponges with a variety of potent biological activities within the literature coverage from 1991 to 2016. Nazumamide A (210) was isolated from the marine sponge Theonella sp. in 1991 and displayed inhibition of thrombin with an IC 50 In 2005, some highly cytotoxic polypeptides with 48 amino acid residues, such as polytheonamides A (229), B (230), and C (231) were isolated from the marine sponge Theonella swinhoei collected from Hachijo-jima Island. They were tested against P388 murine leukemia cells with IC 50 values of 15.5 × 10 −6 , 13.51 × 10 −6 , and 13.48 × 10 −6 μM, respectively [87, 88] , and polytheonamide B (230) exhibited cytotoxicity against HeLa human uterine cervix carcinoma cells with an IC 50 value of 0.58 nM [89] , L1210 murine lymphocytic leukemia cells with an IC 50 < 0.8 nM [90] , and Neuro-2a mouse neuroblastoma cells with an IC 50 < 0.2 nM [91] . In 2005, the chemical investigation of marine sponge Theonella sp. collected off Shimo-koshiki-jima Island, Kagoshima, led to isolation of the koshikamide A 2 (232) , which exhibited moderate cytotoxicity against P388 cells with an IC 50 value of 4.6 μM [92] . A chlorinated peptide, sintokamide A (233), was isolated from the marine sponge Dysidea sp. collected in Indonesia in 2008, which was found to be an inhibitor of N-terminus transactivation of the androgen receptor in prostate cancer cells with an IC 50 In 1996, aciculitins A-C (236-238) were isolated from the lithistid sponge Aciculites orientalis (Negros, Siquijor, Philippines). Aciculitins A-C were cytotoxic to the human colon tumor cell line HCT-116 with an IC 50 of 0.5 μg/mL and inhibited the growth of Candida albicans at a loading of 2.5 μg/disk in the standard disk assay [95] . Through bioassay-guided separation, arenastatin A (239) was isolated from the marine sponge Dysidea arenaria (Okinawan, Japan) in 1995, which exhibited extremely potent cytotoxicity with IC 50 of 5 pg/ml against KB cells [96] . In 1998, a chlorate cyclic depsipeptide, cyclolithistide A (240), was isolated from the marine sponge Theonella swinhoei. It is important to note that cyclolithistide A exhibited significant antifungal activity against Candida albicans (ATCC 24433) in the agar disk diffusion assay. At a dose of 20 μg/disk, the inhibition activity was comparable to 90% of the standard, nystatin at a dose of 100 μg/disk [97] . (244) were isolated from the marine sponge Theonella swinhoei (Tanegashima Island, Tokyo, in July 1993) as a series of potent serine protease inhibitors. In the inhibitory assays against thrombin and trypsin, cyclotheonamide A, E, E2, and E3 exhibited significant inhibition activities with IC 50 values of 23 and 16 nM, 2.9 and 30 nM, 13 and 55 nM, and 9.5 and 52 nM, respectively [98] . 99] . Nine cyclodepsipeptides, homophymines B-E (246-249) and A1-E1 (250) (251) (252) (253) (254) , were also isolated from the polar extracts of the sponge Homophymia sp. (New Caledonian, in 1992). Homophymines displayed very potent antiproliferative activity (IC 50 (255) and jaspamides B-P (256-269) were isolated from the marine sponge Jaspis splendens. All tested jaspamide derivatives exhibited antiproliferative activities with IC 50 values ranging from 0.01 to 33 μM against human breast adenocarinoma (MCF-7) and colon carcinoma (HT29) cell lines [101] . Jaspamides B and C exhibited cytotoxicity against the human NSCLC-N6 cancer cell line with IC 50 values of 3.3 and 1.1 μg/mL, respectively [102] . Jaspamides Q and R together with jaspamide exhibited potent activities against mouse lymphoma (L5178Y) cell lines with IC 50 values in the ng/mL range (<0.1 μg/mL, <0.16 μM) [103] . . Keramamide E exhibited cytotoxicity against L1210 murine leukemia cells and human epidermoid carcinoma KB cells with IC 50 values of 1.60 and 1.55 μg/mL, respectively, while keramamides G, H, and J showed weak cytotoxicity (IC 50 ~10 μg/mL) [105] . Keramamide F showed cytotoxicity against human epidermoid carcinoma KB cells and murine lymphoma L1210 cells with IC 50 values of 1.4 and 2.0 μg/mL, respectively [106] . Motuporin (282), a cyclic pentapeptide, was isolated from the marine sponge Theonella swinhoei (Papua, New Guinea, 1992). Motuporin inhibited protein phosphatase-1 in a standard phosphorylase phosphatase assay at a concentration of < l nM, making it one of the most potent PPl inhibitors known, and it also displayed considerable in vitro cytotoxicity against murine leukemia (P388: IC 50 6 μg/mL), human lung (A549: IC 50 2.4 μg/mL), ovarian (HEY: IC 50 2.8 μg/mL), colon (LoVo: IC 50 2.3 μg/mL), breast (MCF-7: IC 50 12.4 μg/mL), and brain (U373MG: IC 50 2.4 μg/mL) cancer cell lines [108] . The chemical investigation of marine sponge Theonella swinhoei (Malaita Island, Solomon Islands, in July 2004) resulted in the isolation of nine cyclopeptides, perthamides C-K . Perthamides were proved to inhibit TNF-α and IL-8 release in primary human keratinocytes cells and therefore could represent potentially leads for the treatment of psoriasis [111, 112] . A proline-rich cyclic octapeptide, hymenistatin 1 (295) , was isolated from the sponge Hymeniacidon sp. (Palau, Western Pacific Ocean, 1985), which was found to be active against the P388 leukemia cell line (ED 50 3.5 μg/mL) [113] . Axinastatin 1 (296), a proline-rich cyclic peptide, was isolated from the marine sponge Axinella sp. (Palau, Western Pacific, in 1985), with P388 lymphocytic leukemia inhibitory activity (ED 50 0.21 μg/mL) [114] . In 1993, axinastatin 4 (297), another proline-rich cycloheptapeptide, was isolated from marine sponge Axinella cf. (collected in western Indian Ocean, The Republic of The Comoros), which showed comparable cell growth inhibitory activity against a series of human cancer cell lines (P388 lymphocytic leukemia cell line, ED 50 = 0.057 μg/mL) [115] . In 1993, a cyclic heptapeptide, hymenamide B (298), with a prolylproline segment was isolated from the marine sponge Hymeniacidon sp. (Okinawan, Japan). Hymenamide B showed cytotoxicity against murine lymphoma L1210 cells and human epidermoid carcinoma KB cells with IC 50 value of 3.2 and 6.0 μg/mL in vitro, respectively [116] . , which appeared moderate antitumor activity (P388 murine leukemia ED 50 7.5 μg/ml) [117] . In 1995, cyclic heptapeptide phakellistatin 2 (300) was isolated from the marine sponge Phakellia carteri, showed cell growth inhibitory activity of ED 50 0.34 μg/ mL against the P388 lymphocytic leukemia cell line [118, 119] . Phakellistatin 4 (301) isolated from Phakellia costata, showed GI 50 values of about 0.6 μM in different human cancer cell lines [119] . Phakellistatin 5 (302), a metabolite of marine sponge Phakellia costada collected from the Federated States of Micronesia (Chuuk), exhibited significant cell growth inhibitory activity to the P388 murine lymphocytic leukemia and the human cancer cell lines representing ovarian (OVCAR-3), CNS (SF295), lung (NCI-H460), prostate (DU-145), colon (KM20L2), and melanoma (SK-MEL-5) cancers, with GI 50 values ranging from 0.14 to 0.74 μg/ mL [120] . In 2003, cyclodecapeptide designated phakellistatin 12 (303) was isolated as a trace (1.7 × 10 −6 % yield) constituent of the Western Pacific Ocean (Federated States of Micronesia-Chuuk) sponge Phakellia sp. with activity against P388 lymphocytic leukemia ED 50 2.8 μg/mL [121] . A cyclic heptapeptide phakellistatin 13 (304) isolated from the sponge Phakellia fusca Thiele, collected off Yongxing Island of China, in 1998, exhibited potent cytotoxicity against the human hepatoma BEL-7404 cell line with an ED 50 < 2 μg/mL [122] . [123] . The synthetic cyclic peptides of phakellistatins were chemically but not biologically identical with the natural products [116] [117] [118] [119] . 50 values of 4.9 and 9.7 μM, respectively, but with no activity against leukemia HL-60 and hepatoma HepG2 (IC 50 > 20.0 μM) and cervical HeLa (IC 50 17.3 μM) cells [124] . (316) showed potent anti-TB (Mycobacterium tuberculosis) activity with MIC 90 values of 2 and 5 μM, respectively. Callyaerin A showed strong anti-TB activity, but not cytotoxic to THP-1 (the human monocytic cell line) or MRC-5 (the human fetal lung fibroblast cell line) cells (IC 50 > 10 μM), which indicated the potential of these compounds as promising anti-TB agents. Callyaerins E (317) and H (318) exhibited strong activity against the L5178Y cell line with ED 50 values of 0.39 and 0.48 μM, respectively. On the other hand, callyaerin A also showed strong antifungal activity toward C. albicans. Callyaerin G (319) was found to be cytotoxic toward the mouse lymphoma cell line (L5178Y) and HeLa cells with ED 50 (s) of 0.53 and 5.4 μg/mL, respectively [98] . Marine aliphatic polyketides are a class of compounds that present diverse and interesting biological properties. Due to the versatility of their biosynthetic production mechanism, these compounds exhibit remarkable diversity, both in terms of structural complexity and biological activity. Polyketides are constructed as highly oxygenated stereo chemically enriched scaffolds, sometimes with the characteristic presence of macrocyclic lactones, cyclic five-or six-membered ethers, or polyethers that act as a conformational constraint. This review summarizes the isolation, structure identification of a diverse 104 polyketides from 23 genera of marine sponges with a variety of potent biological activities within the literature coverage from 1968 to 2016. Phormidolide A, first isolated from the cyanobacterium Phormidium sp., which is toxic to brine shrimp (LC 50 = 1.5 μM) [125] , together with two new cytotoxic macrolides named phormidolides B (320) and C (321), were identified from a sponge of the Petrosiidae family, collected off the coast of Pemba (Tanzania), in 2014 [126] . Cytotoxic activities tested using three human tumor cell lines, lung (A549), colon (HT29), and breast (MDA-MB-231), manifested that phormidolides B and C have significant cytotoxic activities against these three cell lines with IC 50 around 0.5-1.4 μM [126] . The fact of original discovery from a cyanobacteria species suggested that phormidolide A (322) is actually metabolite synthesized by symbiotic cyanobacterium of the sponge, supporting the relevance of symbiotic bacteria as sources of bioactive polyketides and peptides in sponges. Plakilactones and gracilioethers are oxygenated polyketides of the plakortin family isolated from the marine sponge Agelas gracilis, collected in southern Japan, in 2009 [127] and Plakinastrella mamillaris, collected at the Fiji Islands, in 2012-2013 [128] [129] [130] . In bioassay-guided fractionation of the lipophilic sponge Agelas gracilis extract, Fusetani et al. obtained three new antimalarial compounds against Plasmodium falciparum, gracilioethers A-C (323-325), with IC 50 values of 0.5-10 μg/mL, whereas gracilioether B also showed antileishmanial activity [127] . A few years later, the Zampella group isolated several plakilactone-and gracilioetherpolyketides, together with the previously known gracilioethers A-C compounds from another sponge Plakinastrella mamillaris. Among them, gracilioether B, gracilioether C, and plakilactone C (326) demonstrated activation of PPARγ in a dosedependent manner with relative EC 50 values of ≈ 5, 10, and 2 μM, respectively, and further mechanism study demonstrated that gracilioether B and plakilactone C covalently bind to the PPARγ substrate domain through a Michael addition reaction involving a cysteine residue and the α,β-unsaturated ketone group in their side chains, whereas gracilioether C is a noncovalent agonist for PPARγ [128] . In additon, gracilioether H (327) inhibited chloroquine-resistant CR FC29 strain in vitro with the antiplasmodial activity of IC 50 (342) from Candidaspongia sp., collected in Papua New Guinea, in 2011(isolated as an inseparable mixture of two isomers in equilibrium) [137] , exhibited highly cytotoxic in the subnanomolar to nanomolar range against various cancer cell lines. Cell-flow cytofluorometry analysis revealed that tedanolide caused accumulation of cells in the S phase at concentration as low as 0.01 μg/mL [134] . 13-Deoxytedanolide (343) showed remarkable cytotoxicity against P388 murine leukemia cells with IC 50 's of 94 pg/mL. 13-Deoxytedanolide also performed highly in vivo antitumor activity against P388: T/C = 189% at a dose of 0.125 mg/kg [135] . Tedanolide C exhibited potent cytotoxicity against HCT-116 cells in vitro with IC 50 value of 9.53 × 10 −8 M and caused a strong S-phase arrest [136] . Precandidaspongiolides A and B showed excellent selectivity against melanoma cell lines in the NCI 60-cell line screen, and the LC 50 values for precandidaspongiolides A/B against melanoma cell lines were significantly lower than other tumor cell lines (seven of the nine melanoma cell lines in the panel had nanomolar LC 50 values around 19-174 nM); further, precandidaspongiolides A/B were evidenced as P-gp substrates [137] . Studies of SARs of 13-deoxytedanolide [135] , precandidaspongiolides A and B, and candidaspongiolides A and B [137] reported that the southern hemisphere of 13-deoxytedanolide comprised the pharmacophore and the epoxide-bearing side chain of 13-deoxytedanolide was essential for the activity [138] ; the hemiketal of precandidaspongiolide B and candidaspongiolide B was not essential for the activity, while potency was affected when the primary alcohol of precandidaspongiolides A and candidaspongiolide A was substituted, and the C-7 acetylation of candidaspongiolides A and B increased potency [137] . The similarities between the myriaporones [139] and the candidaspongiolides [137] afforded further evidence in support of microbial symbionts as producers of candidaspongiolides, 13-Deoxytedanolide [140] and candidaspongiolide A [141] . However, the underlying reasons for the candidaspongiolides' melanoma selectivity have yet to be determined. Lehualides are polyketide derivatives isolated from sponge of the genus Plakortis, which have a long alkyl chain with varying degrees of saturation and incorporate α-or γ-pyrone moieties, coupled with thioacetate or thiol functionalities [142, 143] . [148] , in Kerama Islands, Okinawa [149] and in Okinawan [150] ) and Adocia (collected from the Eten Island area of Truk Lagoon in January 1984 and November 1985 at 5-10 m depths [151] and Manado, Indonesia, on May 15, 1993 [152] ), which showed a number of biological activities [146, 147, 151, 152, [148] [149] [150] . In vitro assays and preliminary SAR studies (in 2010) showed that among the compounds 1-8, halenaquinone appeared as the most PLA 2 inhibitor of the series with an IC 50 of 3.7 μM. Incorporating a dioxothiazine unit in compounds 2 and 3 led to a 30-to 40-fold decrease in potency when compared with the most active pentacyclic polyketide 1, and among pentacyclic polyketide compounds, the presence of a secondary alcohol at C-3 rather than a ketone abolished PLA 2 inhibition (4 and 5). These results highlighted that the C-3 oxidation state and the presence of quinone ring E were important for the anti-PLA 2 activity [27, 146] . Similar conclusions were reported regarding the SAR of protein tyrosine kinase inhibition exhibited by halenaquinone (1) [147] . Farnesyltransferase (FTase) inhibitory experiments showed that the presence of dioxothiazine substitution (IC 50 1 1.57 μM vs. 2 1.48 μM and 3 3.75 μM) led to little variation in human (FH) FTase inhibitory activity. Interestingly tetrahydrohalenaquinones A (4) and B (5) did not show such activity. Furthermore, quinol sulfates 6 (IC 50 16.11 μM) and 7 (IC 50 6.71 μM) exhibited modest activity suggesting that the presence of a quinone moiety was essential for FTases inhibitory activity. Sub-micromolar inhibition of farnesyltransferase enzyme of orhalquinone 8 (IC 50 0.40 μM), highlighting this scaffold as a significant modification for enhancing activity [146] . Antiplasmodial activities against FcB1 and 3D7 Plasmodium falciparum strains revealed that compound 2, 3, and 8 were the most active of the series with values of IC 50 [152] and P. simplex (collected at the Caribbean Sea) in 1999 [153] . All compounds exhibited a strong in vitro antimalarial activity against D10 (chloroquine-sensitive) and W2 (chloroquine-resistant) strains of Plasmodium falciparum, with a more potent activity on the W2 strain (IC 50 ~ 180 ng/mL), lacking of cytotoxicity [154] . Plakortide I is purified from an unidentified sponge of the genus Plakortis and collected at Discovery Bay, Jamaica, in 2002 and represented the first report of an endoperoxide with an α,β-unsaturated ketone moiety in the "western" alkyl side chain and exhibited significant antimalarial activity against the W2 strain with an IC 50 value of 570 ng/mL and a selectivity index of >8.4 [155] . Plakortides M (363) and N (364) were isolated from the sponge P. halichondroides, collected in Puerto Rico, in 2003, which exhibited potent cytotoxic activity against a number of cancer cell lines in the NCI human cancer screening program but with less selectivity [156] . Peroxyketal polyketides peroxyplakoric A 3 (365) and B 3 (366) esters isolated from Plakortis sp., collected at Zamami Island, Okinawa Prefecture, in 1993, showed IC 50 = 50 ng/mL against P. falciparum with a selective toxicity index (about 200) [157] . SAR studies played crucial roles in both "western" alkyl side chain and the conformational behavior of the dioxane ring of these compounds according to the interaction with the Fe(II)-heme [158, 159] . [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] . It is remarkable to note that the first compound of this class of toxic polyketides, pederin, was isolated in 1953 from the beetle Paederus fuscipes [161] . The presence of pederin class of polyketides in such taxonomically distinct organisms indicated the possible microbial origin of these compounds. Pederins exhibited multiple interesting pharmacological activities. Pederin (368), the chemical defense agent of the blister beetle, and mycalamides A (369) and B (370) were reported to disrupt protein synthesis [161, 162, 164] . Furthermore, mycalamides A and B together with mycalamides C (371) and D (372) showed potent activity against the P388 murine leukemia cell line, giving IC 50 values of 3.0, 0.7, 95.0, and 35.0 ng/mL, respectively [164, 168] . Theopederins A-L (373-384) were markedly cytotoxic against P388 murine leukemia cells with the activity of nM level [165, 167, 171] . 13-Des-Omethyl-onnamide A (385), dihydroonnamide A (386), onnamide B (387), l7-oxoonnamide B (388), onnamide C (389), onnamide D (390), and onnamide A (391) were highly cytotoxic against the P388 cell line with IC 50 values of 0.15, 0.04, 0.13, 0.10.0.07, 0.02, and 0.01 μg/mL, respectively [166] . Onnamide F (392) was active against fungi Saccharomyces cerevisae with a value of LD 99 1.4 μg/mL. No activity was observed against Bacillus subtilis or Eschericha coli, indicating a selective toxicity for eukaryotes [170] . Icadamides A (393) and B (394) were reported to show in vitro cytotoxicity against HCT-116 human colon carcinoma cell line with IC 50 value of 63 nM and 0.17 nM, respectively. Among pederin type of compounds, only icadamide B (395) was studied for in vivo antitumor activity and exhibited activity against intraperitoneally and subcutaneously implanted tumors such as P388 mouse leukemia, M109 mouse lung tumors, and asbestos-induced pulmonary squamous cell carcinoma. Icadamide C displayed potent cytotoxic activity against a small panel of five human solid tumor cell lines (A549, SK-OV-3, SK-MEL-2, XF-498, and HCT-15) with ED 50 values of less than 0.1 μg/mL [160] . [172, 173, 78, [174] [175] [176] , unique polyketides bearing nitrogen and phosphorus functions. These macrolides exhibited a variety of biological activities including antitumor and smooth muscle contractile, which are attributed to inhibition of protein phosphatase 1 and 2A (all these compounds exhibited nM scale of inhibition activity). SAR studies showed that the 17-phosphate, 13-hydroxyl, and the hydrophobic tetraene moieties were all necessary for binding to the phosphatase 1 and 2A [176] . The sponge-derived polyketide macrolides fijianolides are an important subset of 20-membered ring containing compounds isolated from marine sponge Cacospongia mycofijiensis, Hyatella sp., and Fasciospongia rimosa [177] [178] [179] [180] . Fijianolide B extremely potent (KB a IC 50 = 29 nM, MDA-MB-435 IC 50 = 5.7 nM), while fijianolide A (414) (HT29 IC 50 = 21 μM, KB IC 50 > 39 μM, MDA-MB-435 IC 50 = 2 μM) was also very active but at a reduced potency [181, 182] . Neolaulimalide (415) showed cytotoxicity against P388, A549, HT29, and MEL28 cell lines at 0.01-0.05 μg/mL [180] . Fijianolide B (416) together with fijianolides E (417) and G (418) were also shown to disrupt interphase and mitotic division, and fijianolide B was more potent than fijianolides E and G [177] . An in vivo evaluation of fijianolide B using tumor-bearing severe combined immuno-deficiency mice demonstrated significant inhibition of growth of HCT-116 tumor cells over 28 days [177] . Spiculoic acids and zyggomphic acids are indane-type polyketides, which have integrated phenylacetic acid, butyrate, and propionate units, isolated from marine sponge Plakortis zyggompha and P. angulospiculatus [183] [184] [185] . The vast majority of polyketides made in nature are assembled from acetate and propionate building blocks, whereas these spiculoic acids and zyggomphic acids incorporated the intact of butyrate units. Furthermore, the location of the olefin functionality formed by reduction of the β ketone and dehydration after condensation of the phenylacetic acid starter unit with the first butyrate is unusual. Normally, the dehydration step in polyketide biosynthesis would yield an α,β-unsaturated ester. In the biosyntheses of these polyketides, dehydration occurs in the opposite direction, leading to conjugation between the olefin and the phenyl ring [184] . Spiculoic acid A (419) showed in vitro cytotoxicities against the breast MCF-7, breast MDA-MB-231, lung carcinoma A549, and colon carcinoma HT29 cell lines with IC 50 values of 8.0, 2.4, 4.6, and 8.1 μg/mL, respectively [183, 184] . Zyggomphic acid (420) exhibited in vitro antitumor activities against the breast MDA-MB-231, lung carcinoma A549, and colon carcinoma HT29 cell lines with IC 50 values of 1.2, 3.3, and 3.6 μg/mL, respectively [183] . Dihalenaquinolides A (421) and B (422), novel pentacyclic polyketide dimers, were isolated from marine sponge Petrosia elastica collected in Nan-wan, Taiwan, during June 1998 [186] . Dihalenaquinolide A inhibited the growth of PC-3 tumor cells at 10 μg/mL, while compound dihalenaquinolide B was inactive [186] . Callystatin A (423) is a novel polyketide with a terminal α,β-unsaturated δ-lactone, isolated from the marine sponge Callyspongia truncata, collected at Goto Islands, Nagasaki Prefecture, in 1997 and exhibited potent cytotoxicity against KB cells at IC 50 0.01 ng/ml. Through analogue, syntheses and the assessment of their biological potencies against KB cells manifested the ketonic carbonyl, the 19-hydroxyl, and the three asymmetric methyl groups located in the β-hydroxyketone part of callystatin A contributing to the cytotoxic potency, respectively. Moreover, the α,β-unsaturated δ-lactone portion served as a conclusive functional group for the cytotoxic activity [187] . Natural products possessing a macrocyclic lactone moiety are considered to be "macrolides," and most of them are likely to belong to polyketides from a biogenetic viewpoint. Because so many macrolides have been reported in recent years, the selection of compounds derived from 36 marine sponges may seem arbitrary and depends on the potency of their biological activities reported from year 1984 to year 2014. In 1984, tedanolide (424) was isolated from Tedania ignis (Caribbean), which exhibited highly cytotoxic with ED 50 2.5 × 10 −4 μg/mL in KB (human carcinoma of the nasopharynx) and 1.6 × 10 −5 μg/mL in PS (lymphocytic leukemia) [134] . Eight antitumor compounds including norhalichondrins A-C (425-427), homohalichondrins A-C (428-430), and halichondrins B (431) and C (432) were found from Halichondria okadai Kadota (Miura Peninsula, Tokyo) in 1986, among which halichondrin B exhibited remarkable in vivo antitumor activity [188] . In 1987, halichondramide (433), dihydrohalichondramide (434), and isohalichondramide (435) were isolated from the Pacific sponge Halichondria sp. (Kwajelein Island), among which halichondramide showed significant activity against Candida albicuns at 0.01 μg/disk in the standard disk assay [189] , and dihydrohalichondramide and isohalichondramide had antifungal activity and inhibited cell division in the fertilized sea urchin egg assay [190] . In 1989, mycalolides A-C (436-438) were isolated from a sponge Mycale sp. (Kii Peninsula, Japan) and demonstrated antifungal activities against many pathogenic fungi and cytotoxic against B-16 melanoma cells with IC 50 s of 0.5-1.0 ng/mL [191] . The chemical investigation of Okinawan marine sponge Jaspis sp. in 1993 yielded jaspisamides A-C (439-441) which exhibited cytotoxicities against L1210 murine leukemia cells in vitro, with IC 50 values of <0.001, <0.001, and < 0.001 μg/mL, and against human epidermoid carcinoma KB cells in vitro with IC 50 values of 0.015, 0.006, and 0.013 μg/mL, respectively [192] . In 1988, an Indonesian sponge Hyattella sp. was collected offshore from Manado (northern Sulawesi, Indonesia) yielded laulimalide (442) and isolaulimalide (443), and laulimalide displayed potent cytotoxicity, IC 50 = 15 ng/mL, against the KB cell line [179] . Swinholide A (444) was first isolated from a Red Sea sponge Theonella swinhoei (Gulf of Eilat, Israel, in 1985), demonstrating in vitro antifungal activity [193] . It was re-isolated from the Okinawan marine sponge Theonella swinhoei in 1989 and exhibited potent cytotoxic activity (IC 50 0.04 μg/mL) for KB cell [194] . Its absolute configuration was elucidated by means of the X-ray diffraction method and chemical derivations in 1990 [195] . Then, in 1990, swinholide B (445), swinholide C (446), and isoswinholide A (447) were also found from the Okinawan marine sponge Theonella swinhoei, among which, swinholide B and swinholide C exhibited potent cytotoxicity almost equivalent to that of swinholide A toward KB cell lines (IC 50 0.041 and 0.052 μg/mL, respectively), while isoswinholide A showed weaker cytotoxicity (IC 50 1.1 μg/mL) [196] . In 1993, altohyrtins A-C (448-450) and 5-desacetylaltohyrtin A (451) were found in sponge Hyrtios altum, which were of great interest for cytotoxic activities against KB cells with IC 50 values of 0.01, 0.02, 0.4, and 0.3 ng/mL, respectively [94, 197, 198] . A highly potent polyether macrolide antimitotic agent designated halistatin 1 (452) was isolated from Phakellia carteti (Grand Comore Island, Republic of Comoros), which showed strong cytotoxicity to L1210 murine leukemia cells with IC 50 values of 0.5 nM. In the further mechanism study, it was shown to cause accumulation of cells arrested in mitosis, inhibited tubulin polymerization, and inhibits binding of radiolabeled vinblastine and GTP to tubulin [199] . Cinachyrolide A (453) was isolated from Cinachyra sp. which was highly cytotoxic against L1210 murine leukemia cells with an IC 50 of <0.6 ng/mL [200] . In 1994, superstolides A (454) and B (455) were obtained from the deepwater marine sponge Neosiphonia superstes (New Caledonia) and demonstrated highly cytotoxic against human bronchopulmonary non-small-cell lung carcinoma NSCLC-N6-L 16 cells (IC 50 0.04 and 0.039 μg/mL), murine leukemia P388 cells (IC 50 both of 0.003 μg/ mL), and human nasopharyngeal carcinoma KB cells (IC 50 0.02 and 0.005 μg/mL) [201, 202] . Reidispongiolides A (456) and B (457) were isolated from Rekiivpmgia werulea n.gen. n.sp. (South of New Caledonia), which exhibited potent cytotoxicity against various human carcinoma cells with IC 50 values of 0.01-0.16 μg/mL [203] . Lasonolide A (458) was isolated from Forcepia sp. (British Virgin Islands), as a potent cytotoxin against the A549 human lung carcinoma and P388 murine leukemia cell lines with IC 50 values of 40 and 2 ng/mL, respectively. Further, it inhibited cell adhesion in the EL-4.IL-2 cell line with an IC 50 of 19 ng/mL [204] . Isohomohalichondrin B (459) was found in New Zealand sponge Lissodendoryx sp. and showed significant cytotoxic activity against the P388 cell lines and selective cytotoxicity in the NCI'S primary screen [205] . The chemical investigation of Indian Ocean marine sponge Phorbas sp. (Muiron Island, Australia, in 1995) yielded phorboxazoles A (460) and B (461), which exhibited in vitro antifungal activity against Candida albicans at 0.1 μg/disk and extraordinary cytostatic activity [206] . In 1996, theonezolide A (462), a novel polyketide macrolide, isolated from the Okinawan marine sponge Theonella sp. (Okinawa, Japan), caused a marked platelet shape change at low concentrations (0.2-0.6 μM) [207] . Leucascandrolide A (463), a doubly O-bridged 18-membered macrolide of a new type, i.e., possessing little C 1 -branching vs. extensive 1,3-dioxygenation and a peculiar side chain, was isolated from a calcareous sponge of a new genus, Leucuscundra caveoluta from the Coral Sea. It showed strong cytotoxic activity in vitro on KB cells and less marked action on P388 cells, as well as very strong inhibition of Candida albicans [208] . Compared with leucascandrolide A, leucascandrolide B (464) was found from the same sponge sample which showed only marginal cytotoxicity on tumor cell lines, with an IC 50 of 5 μg/mL on KB cells and > 10 μg/mL on P388 murine leukemia cells and no activity on Candida albicans [209] . A marine sponge Fasciospongia rimosa (Okinawa, Japan) yielded zampanolide (465) which showed potent cytotoxicity (IC 50 1-5 ng/mL) against P388, A549, HT29, and MEL28 cell lines [210] . In 1997, study of a deepwater sponge Lissodendoryx sp. (Kaikoura Peninsula, New Zealand) yielded neonorhalichondrin B (466), neohomohalichondrin B (467), 55-methoxyisohomohalichondrin B (468), 53-methoxyneoisohomohalichondrin B (469), and 53-epi-53methoxyneoisohomohalichondrin B (470), and further antitumor assay demonstrated that they were highly cytotoxic against P388 cells with IC 50 values of 0.4, 0.8, 10, and 0.1 ng/mL except 53-epi-53-methoxyneoisohomohalichondrin B, respectively [211] . Two novels, highly potent, cytotoxic macrolides and salicylihalamides A (471) and B (472), were isolated from the sponge Haliclona sp. (Rottnest Island, Australia) . COMPARE pattern-recognition analyses of the NCI 60-cell mean-graph screening profiles of salicylihalamide A did not reveal any significant correlations to the profiles of known antitumor compounds in the NCI's "standard agent database," thus supporting the conclusion that the salicylihalamides represent a potentially important new class for antitumor lead optimization and in vivo investigations [212] . In 1998, thiomycalolides A (473) and B (474) were obtained from Mycale sp. (Kii Peninsula, Japan), which exhibited highly cytotoxic against P388 murine leukemia cells with an IC 50 value of 18 ng/mL each [213] . Chemical investigation of an Okinawan sponge Ircinia sp. resulted in isolation of haterumalides NA, NB, NC, ND, and NE (475-479), among which, haterumalides NA exhibited cytotoxicity against P388 cells, with an IC 50 of 0.32 μg/mL, and moderate acute toxicity against mice, with an LD 99 of 0.24 g/kg which was found in 1999 [214] . In 2000, antiproliferative bioassay-guided fractionation of an aqueous extract of the marine sponge Chondropsis sp. (Wollongong, Australia) provided chondropsins A (480) and B (481). Testing of chondropsin A in the NCI 60-cell screen revealed a mean-graph profile that did not correlate significantly with the profile of any compound class represented in the NCI standard agents database [215] . In 2001, 73-deoxychondropsin A (482) and chondropsin C (483) were isolated from two different collections of marine sponges belonging to the genus Ircinia (Ircinia ramose, Australia; Ircinia sp., Philippines) and exhibited IC 50 's of approximately 0.8 and 0.2 ng/mL toward the LOX and MOLT-4 cell lines, respectively [216] . Chondropsin D (484) exhibited IC 50 's of approximately 10 and 250 ng/ mL toward the LOX and MOLT-4 cell lines, respectively [217] . In 2000, peloruside A (485) was found to be cytotoxic to P388 murine leukemia cells at approximately 10 ng/mL (18 nM) which was found in sponge Mycale sp. [218] . In 2010, peloruside B (486), a natural congener of peloruside A, was isolated from the New Zealand marine sponge Mycale hentscheli. Peloruside B was found to promote microtubule polymerization and arrest cells in the G2/M phase of mitosis similar to paclitaxel, and its bioactivity was comparable to that of peloruside A [219] . In 2001, dactylolide (487) from Dactylospongia sp. showed cytotoxic activity against the L1210 and SK-OV-3 tumor cell lines (63% and 40% inhibition at 3.2 μg/ mL) [220] . In 2002, 30,32-dihydroxymycalolide A (488) was obtained from Mycale izuensis, with cytotoxic activity against HeLa cells (IC 50 value of 2.6 ng/mL) [221] . In 2005, 13-deoxytedanolide (489), a highly antitumor macrolide from the marine sponge Mycale adhaerens, exhibited cytotoxic activity against P388 murine leukemia cells with IC 50 of 0.064 ng/mL [138] . In 2006, tedanolide C (490) isolated from Ircinia sp. (Milne Bay, Papua New Guinea) exhibited potent cytotoxicity against HCT-116 cells in vitro with IC 50 value of 9.53 × 10 −2 μM and caused a strong S-phase arrest [136] . Leiodolides A (491) and B (492) were found in marine sponge Leiodermatium (Palau) from deep water, and leiodolide A showed significant cytotoxicity (average GI 50 = 2.0 μM) in the National Cancer Institute's 60 cell line panel with enhanced activity against HL-60 leukemia and OVCAR-3 ovarian cancer cell lines [222] . The Red Sea sponge Theonella swinhoei (Hurghada, Egypt) yielded swinholide I (493) and hurghadolide A (494) which were in vitro cytotoxic against human colon adenocarcinoma (HCT-116) with IC 50 values of 5.6 and 365 nM, respectively. Furthermore, they could disrupt the actin cytoskeleton in the range of 70 and 7.3 nM, respectively. In addition, they were both active against Candida albicans [223] . In 2007, neopeltolide (495) was isolated from a deepwater sponge of the family Neopeltidae (Jamaica), and it showed potent in vitro anti-proliferation activity against A549 human lung adenocarcinoma, the NCI-ADR-RES human ovarian sarcoma, and the P388 murine leukemia cell lines, with IC 50 's of 1.2, 5.1, and 0.56 nM, respectively. Neopeltolide also inhibited the growth of the fungal pathogen Candida albicans with a minimum inhibitory concentration of 0.62 μg/mL [224] . The study of marine sponge Poecillastra sp. (Grand Bahama Island, Bahamas) yielded poecillastrins B (496) and C (497), which were of interest for cytotoxicity against a human melanoma tumor cell line (LOX) with an IC 50 value of less than 1 μg/mL [225] . In 2008, mirabilin (498) was isolated from the marine sponge Siliquariaspongia mirabilis (Federated States of Micronesia), which prevented the tumor cell line HCT-116 from growing with an IC 50 value of 0.27 ± 0.09 μM [226] . Three nitrogenous macrolides designated salarin A (499), B (500) and tulearin A (501) were isolated from the Madagascar Fascaplysinopsis sp. sponge. Both salarins carry an acetylcarbamate moiety, and in addition, salarin A contains a triacylamine group and salarin B contains a methoxymethylketone lactam. Tulearin A was featured with a naturally rare carbamate ester. They were found to be toxic to brine shrimp larvae, and salarin A and tulearin A were also cytotoxic to leukemia cells [227] . In the year of 2009, the deepwater marine sponge Lissodendoryx sp. (Kaikoura Peninsula, New Zealand) was found to contain halichondrin B-1140, halichondrin B-1092, halichondrin B-1020, and halichondrin B-1076 (502-505), which exhibited highly cytotoxicity against the P388 cell lines with IC 50 values of 2.0, 0.76, 1.1, and 1.1 ng/mL, respectively [228] . Leiodermatolide (506) isolated from the marine sponge Leiodermatium sp. (Fort Lauderdale, Florida,2011) was found to exhibit potent and selective antimitotic activity (IC 50 < 10 nM) against a range of human cancer cell lines by inducing G2/M cell cycle arrest [229] . Kabiramides B-D, G, J, and K (507-512) were isolated from the sponge Pachastrissa nux, showed moderate to strong antimalarial and cytotoxic activities, except for kabiramide G, which possessed only potent cytotoxicity [230] . In 2013, kabiramides L (513) and I (514) were obtained from the same sponge sample Pachastrissa nux, and both exhibited a moderate antiplasmodial activity against Plasmodium falciparum K1 with IC 50 s of 2.6 and 4.5 μM, respectively [231] . In 2014, callyspongiolide (515), a structurally unique polyketide-derived macrolide, was isolated from the marine sponge Callyspongia sp. collected in Indonesia, and it showed strong cytotoxicity against human Jurkat J16 T and Ramos B lymphocytes [232] . Marine organisms produce a wide array of fascinating terpenoid structures distinguished by characteristic structural features. Since sponges are one of the prime resources of sesquiterpenes,diterpenes,sesterterpenes,and triterpenes, we here will survey 170 terpenoids from 32 sponges with various biological activities such as antitumor, anti-inflammation, antifouling, fungicide, as well as pesticide. In 1996, chemical investigation of sponge Acanthella eavernosa (Hachijo-jima Island, Tokyo), yielded Isocyanate and isothiocyanate derivatives 516 and 517, both of which were highly active in antifouling assay with EC 50 value of 0.05 μg/mL [233] . In 2008 year, three new sesquiterpene quinones isohyatellaquinone (518), 7, 8-dehydrocyclospongiaquinone-2 (519), and 9-epi-7, 8-dehydrocyclospongiaquinone-2 (520), along with the known quinones mamanuthaquinone (521) and ilimaquinone (522), were isolated from Dactylospongia elegans (Coral Gardens dive site at the Inner Gneerings reef, Australia, in 2007). All compounds were active against the breast cancer (BC) and small cell lung cancer (NCI-H187) cell lines an IC 50 range of 1.50-12.4 μg/mL except compound 519 [234] . In 2012, a chemical study of sponge Dysidea avara (Xisha islands, South China Sea) resulted in discovery of dysidavarones A-D (532-535), of which dysidavarone A (532) inhibited protein tyrosine phosphatase 1B (PTP1B) with IC 50 value of 9.98 μM. These four compounds are the first example of sesquiterpenes featured with the unprecedented "dysidavarane" carbon skeleton [237] . In 2013, chemical investigation of Euryspongia sp. (Iriomote Island, Okinawa, Japan) revealed the discovery of Euryspongins A-C (536-538). The compounds 536-538 were not active against protein tyrosine phosphatase 1B (PTP1B) while compound 539 (the dehydrated product of 536) tended to inhibite PTP1B with IC 50 value of 3.6 μM, highlighting the importance of the absence of an OH group at C-4 for activity [238] . In 1998, four new norditerpenes (540-543) were isolated from the marine sponge Diacarnus cf. spinopoculum (Solomon Islands). Compounds 540 and 541 showed moderate activity against the NCI's 60 cell line [239] . In 2002, an inseparable mixture, sarcotins K (544) and L (545) were reported from the marine sponge Sarcotragus sp. (Cheju Island, Korea, in July 1998). The mixture was evaluated for cytotoxicity against five human tumor cell lines, but only showed activity against SK-MEL-2 cell line with an ED 50 value of 6.2 μg/mL [240] . In 2011, four novel 9-N-methyladeninium diterpenoids, agelasine M (557), 2-oxo-agelasine B (558), gelasineA (559), and gelasine B (560), together with the known agelasine B (561) and F (562), were isolated from the marine sponge Agelas sp. (Kimbe Bay, Papua New Guinea, in November 2007). Compounds 557 and 562 exhibited potent cytotoxicity against Jurkat cells with IC 50 values of 3.0 and 3.6 μg/ mL while compounds 561 and 562 were strongly active against Trypanosoma brucei with IC 50 values of 8.4 and 3.3 μg/mL [243] . In 2012, two new spongian-class diterpenes (563, 564), along with two known compounds (565, 566), were found in the marine sponge Chromodoris sp. (Okinawa Island), and they showed moderate cytotoxity against NBT-T2 rat bladder epithelial cells with IC 50 values of 5.6, 12, 3.4, and 3.8 μg/mL, respectively [244] . In 2015, chemical investigation of the New Zealand marine sponge Hamigera tarangaensis (Cavalli Island, New Zealand, in December 2003) resulted in the isolation of nine new nitrogenous hamigeran diterpenoids, namely hamigeran M(567), hamigerans N − Q(568-571), 19-epi-hamigeran Q (572), and 18-epi-hamigerans N, P, and Q (573-575). Hamigeran M (567) exhibited potent cytotoxic activity against HL-60 promyelocytic leukemic cell line at 6.9 μM. And in this work, the structure of hamigeran D (576) was revised [245] . In 1991, three new norsesterterpene peroxides, phyllofenone B (593), phyllofolactone A (594), and phyllofolactone B (595), were isolated from the sponge Latrunculia sp. (Jervis Bay, Australia). Among them, phyllofenone B was active against the P388 cell line with an IC 50 value of 5 μg/mL [248] . In 1991, a study of the Adriatic sponge Fasciospongia cavernosa (Yongxing Island, South China Sea, in April 1988) yielded 25-Deoxycacospongionolide B (596), which showed a high cytotoxicity with an EC 50 value of 0.74 μg/mL in the Arremia salina bioassay [249] . In 1998, chemical analysis of Hyrtios erecta (Amami-Oshima, Japan, in 1993) resulted in the discovery of novel scalarane sesterterpenes (597-601), and their stereo structures were characterized by means of spectral analyses, X-ray crystallography, and chemical reactions. Compound 597 showed potent in vitro and in vivo antitumor activities. In addition, the structure-activity relationship was also discussed using computer-assisted structure matching of 597 and aragusterols [250] . In 2002, barangcadoic acid A (602) and rhopaloic acids D-G (603-606) found in the marine sponge Hippospongia sp, were reported to possess RCE protease inhibitory activity [251] . In 2010, a chemical investigation of the South China Sea sponge Phyllospongia foliascens (Yongxing Island, South China Sea, in June 2007) resulted in discovery of a new scalarane sesterterpene, phyllofolactone M (607) [252] . In 2011, two new sesterterpenoids, phorbasones A (631) and B (632), were found from the Korean marine sponge Phorbas sp., and their complete structures were elucidated by spectral data and chemical reactions. Phorbasone A exhibited a positive effect on the calcium deposition activity in C3H10T1/2 cells [256] . In 2015, phorone B (669) and ansellone C (670) structurally close related to the sesterterpenes of the phorone and ansellone classes were isolated from the marine sponge Clathria gombawuiensis (Gageo-do, Korea, on September 9-11, 2006) . The two compounds showed temperate cytotoxic activity against A549 and K562 cell lines with mean IC 50 values in the range 3.9-5.4 μM. The cytotoxicity of 1 may be related to the presence of a free phenolic −OH group, as the corresponding O-methoxy derivative is inactive [263] . O The basic role of sterols is the maintenance of optimal fluidity of cell membranes, although these compounds also serve as precursors for the production of diverse steroid classes such as the polyhydroxylated marine sterols. In recent years, research in the marine sterol field has progressed at an impressive pace. Here we intend to provide a description of the characteristic features of 107 sterols with potent biological activities from 29 marine sponges covering literatures from 1993 to 2015. In 2014, the chemical study of marine sponge Corticium niger collected from the Philippines resulted in the discovery of two new steroidal alkaloids plakinamines N (685) and O (686), which were tested for antiproliferative activity and showed remarkable inhibitory effects against all of the colon cell lines with mean GI 50 values of 11.5 and 2.4 μM [265] . In 2007, a tropical sponge Phorbas amaranthus (Key Largo, Florida) was found to contain a 24-imidazolyl steroidal alkaloid amaranzole A (687). The structure was elucidated on the basis of MS, NMR, exciton-coupled CD spectrum, and comparison with model compounds [266] . In the same year, steroidal alkaloid 4-acetoxyplakinamine B (688) bearing a stigmastane skeleton was found in the Thai sponge Corticium sp. The compound inhibited acetylcholinesterase with IC 50 value of 3.75 μM [267] . A series of steroidal alkaloids cortistatins J-L (689-691) were isolated from the Indonesian marine sponge Corticium simplex. Cortistatin J exhibited potent cytostatic antiproliferative activity against human umbilical vein endothelial cells (HUVECs) at 8 nM [268] . In 2006, four steroidal isoquinoline alkaloids cortistatins A-D (692-695) were obtained from the marine sponge Corticium simplex (Flores Is., Indonesia). These compounds exhibited highly selective antiproliferative activity against HUVECs with IC 50 values of 0.0018, 1.1, 0.019, and 0.15 μM, respectively [269] . In 2003, four steroidal alkaloids, plakinamine I-K (696-698) and dihydroplakinamine K (699), were obtained from a Philippine sponge Corticium niger. These compounds exhibited significant in vitro cytotoxicity against the human colon tumor cell line HCT-116 with IC 50 values of 10.6, 6.1, 1.4, and 1.4 μM, respectively [270] . In 2002, four plakinamine-type steroidal alkaloids were isolated from a marine sponge Vanuatuan Corticium, of which plakinamine G (700) and tetrahydroplakinamine A (701) were quite active against rat glioma cells (IC 50 's 6.8 and 1.4 μg/mL, respectively) [271] . In the year of 1999, chemical study of Corticium sp. from Vanuatu yielded plakinamines C (702) and D (703) and three other steroidal alkaloids (704-706), all of which showed potent cytotoxicity against human bronchopulmonary non-smallcell lung carcinoma cells with IC 50 values of <3.3-5.7 μg/mL [272] . In 2012, two new dimeric sterols manadosterols A (707) and B (708) were found in the sponge Lissodendryx fibrosa in Indonesia, which are potent inhibitors of the Ubc13-Uev1a complex with IC 50 values of 0.09 and 0.13 μM and therefore have potential as anticancer agents [273] . In 2011, shishicrellastatin A and B (709 and 710) , two dimeric steroid derivatives, were reported from the marine sponge Crella (Yvesia) spinulata. Both of them exhibited bioactivity against cathepsin B with an IC 50 value of 6.9 μM each [274] . In 2009, three sulfated sterol dimers, fibrosterol sulfates A-C (711-713), were isolated from Lissodendoryx (Acanthodoryx) fibrosa collected in the Philippines. Fibrosterol sulfate B inhibited protein kinase Cζ with IC 50 value of 5.6 μM [275] . In In 2008, three new marine polar steroids, chlorotopsentiasterol sulfate D (717), topsentiasterol sulfate F (718), and iodotopsentiasterol D (719), were isolated from the marine sponge Topsentia sp. (Vang Fong Bay, Vietnam). Chlorotopsentiasterol sulfate D proved to be an effective inhibitor of endo-1,3-β-D-glucanase [277] . In 2007, sulfated sterol 24ξ,25-dimethyl-3α-hydroxyl-cholest-5-ene-2β-ol sodium sulfate (720) which showed cytotoxicity to four human cancer cell lines was obtained from Halichondria rugosa [278] . In 2007, an undescribed marine sponge Euryspongia was the source of eurysterols A (721) and B (722), with the former being cytotoxicity against human colon carcinoma (HCT-116) cells with IC 50 value of 2.9 μg/mL, also antifungal to amphotericin-B-resistant Candida albicans [279] . In 2003, a sterol sulfate Scheme 572423 (723), along with the known halistanol sulfate, was isolated from a Topsentia species collected in the Bahamas. The compounds were found as P2Y 12 inhibitors with IC 50 of 0.48 and 2.2 μM, respectively [280] . In 2001, a Philippine sponge of the genus Xestospongia yielded two sulfated sterols, ibisterol B (724) and C (725) and an epoxysteroid (726) that were found to be inhibitors of HIV-1 integrase [281] . In 1998, marine sponge Crella sp. from Vanuatu Island yielded crellastatin A (727), a new nonsymmetric dimeric steroid, which exhibited cytotoxic activity against NSCLC-N6 cells with the IC 50 value of 1.5 μg/mL [282] . In 1996, halistanol disulfate B (728), a sterol sulfate, was isolated from the MeOH extract of a South African sponge Pachastrella sp. The compound had an IC 50 In 2014, cinanthrenol A (732), an estrogenic steroid containing phenanthrene nucleus, was isolated from the marine sponge Cinachyrella sp. Absolute configuration of the compound was established as 16S, 17S, and 19S by the modified Mosher's method. Cinanthrenol A bound to estrogen receptor in a competitive manner against estradiol with an IC 50 value of 10 nM. Moreover, it has cytotoxicity against P388 and HeLa cells as well, with IC 50 4.5 and 0.4 μg/mL, respectively [286] . Also in this year, extracts of the sponge Theonella swinhoei, which collected at the Xisha island, yielded two novel sterols swinhoeisterols A and B (733 and 734) with an unprecedented 6/6/5/7 tetracyclic systems. The absolute configurations of the compounds were assigned by X-ray diffraction, TDDFT/ECD calculations, and modified Mosher's method. Swinhoeisterols A exhibit a potent inhibitory activity (IC 50 = 2.9 μM) against the histone acetyltransferase (h)p300 [287] . In 2013, aragusterol I (735), 21-O-octadecanoyl-xestokerol A (736), and 7β-hydroxypetrosterol (737), three cyclopropanated sterols, were isolated from the Vietnamese marine sponge Xestospongia testudinaria [288] . The compound 21-O-octadecanoyl-xestokerol A showed antifouling activity with EC 50 values similar to that of the antifoulant marine pollutant tributyltin oxide. In 2008, aminosteroids clionamine D (738) which has an unprecedented spiro bislactone side chain were isolated from South African specimens of the sponge Cliona celata [289] . In 2004, the Okinawan sponge Terpios hoshinota yielded nakiterpiosin (739) and nakiterpiosinone (740), both exhibiting cytotoxicity potentially against mouse lymphocytic leukemia cells (P388) with IC 50 values of 0.01 mg/mL, respectively [290] . In 2001, Stelletta hiwasaensis from Japan was found to produce orostanal (741), abeo-sterol derivative, which induced apoptosis in human acute promyelotic leukemia cell with IC 50 value of 1.7 μM [291] . In 1999, glaciasterol B 3-monoacetate (742), a new 9,11-secosterol which exhibited potent toxic activity (LC 50 = 0.54 μg/ml) to brine shrimp, was isolated from the Tyrrhenian sponge Fasciospongiu cavernosa [292] . In 1996, an Okinawan marine sponge Xestospongia sp. was found to contain aragusteroketals A (743) and C (744); both of them exhibited potent cytotoxic activity with the same IC 50 value of 4 ng/ml against KB cells [293] . In 1995, pentacyclic steroid xestobergsterol C (745), possessing a cis C/D ring junction, which exhibited cytotoxicity against L-1210 murine leukemia cells with IC 50 values of 4.1 μg/mL, was obtained from the Okinawan marine sponge Ircinia sp. [294] . In 1993, an Okinawan marine sponge of the genus Xestospongia was the source of aragusterol A-D (746-749) [295] [296] [297] , all of which except aragusterol C strongly inhibited the proliferation of KB cells at IC 50 values of 0.042, 3.3, and 0.041 μg/mL, respectively. In the same year, antibacterial compound gelliusterol E (751) was obtained from the Red Sea sponge Callyspongia aff. implexa [299] . Gelliusterol E inhibited the formation and growth of gram-negative bacterium Chlamydia trachomatis in a dose-dependent manner with an IC 50 value of 2.3 μM. In 2012, Okinawan sponge Dysidea sp. was the source of dysideasterols F-H (752-754), all of which inhibited human epidermoid carcinoma cells strongly with a similar cytotoxic effect with IC 50 values of 0.15-0.3 μM [300] . In 2010, an undescribed species of Topsentia was the source of three isopropyl steroids, topsentinols K (755), L (756) and K trisulfate (757); the latter was an inhibitor of BACE1 dose-dependently with an IC 50 In 2009, five norselic acids A-E (758-762) were obtained from the sponge Crella sp. collected in Antarctica, all of which inhibited the growth of the Leishmania parasite at low micromolar levels [302] . Also in 2009, Australian marine sponge Psammoclema sp. contained a series of trihydroxysterols (763-766), of which 4 were cytotoxic against a panel of cancer cell lines [303] . In 2008, Ircinia aruensis collected in Naozhou Island yielded six epoxysterols. Compound 767 exhibited cytotoxicity against four cancer cell lines (7402, H-460, LOVO, and MCF) with IC 50 values of 4.3, 2.8, 5.1, and 3.5 μg/mL, respectively [304] . In 2005, Homaxinella sp. (Korea) contained a series of highly degraded sterols demethylincisterols A 1 -A 4 (768-771) and butoxyderivatised sterols homaxisterols A 1 -A 4 (772-775), all of which but homaxisterols A 4 inhibited a panel of five human solid tumor cell lines, and especially 770 displayed significant cytotoxicity [305] . In 2004, Italian sponge Cliona nigricans provided two polychlorinated steroids clionastatins A (776) and B (777), which exhibited potential antitumor activity in three cell lines with IC 50 values ranging from 0.8 to 2.0 μg/mL [306] . In 2004, four sterols (778-781) were isolated from the marine sponge Axinella cf. bidderi (Yemen, Indian Ocean), which possess, respectively, the cholestene and the cholestane skeleton with a cyclic enol ether linkage between C-18 and C-22. These sterols showed cytotoxic activity against prostate, ovary, pancreas, colon, and lung cell lines with GI 50 values ranging from 0.6 to 8.3 μg/mL [307] . In 2002, three new sterols (782-784), isolated from the marine sponge Polymastia tenax, were found to have potent antiproliferative activity toward A549, HT29, H-116, MS-1, and PC-3 tumor cells in the range 0.5-10 μg/mL [308] . In 2001, an undescribed species of Gellius collected in the Caribbean coast of Panama was the source of four acetylenic sterols, gelliusterols A-D (785-788); 785, 786, and 787 were found to be cytotoxic to a panel of cancer cell lines [309] . In 2000, northern Australia Dysidea sp. yielded three polyoxygenated sterols (789-791) that inhibited the binding of IL-8 to the human recombinant IL-8 receptor-type A with the IC 50 values of 20, 5.5, and 4.5 μM, respectively [310] . A deepwater marine sponge Scleritoderma sp. cf. paccardi which collected from Turneffe Islands (Belize) in 1985 yielded a sterol ether (792) named 24(R)-methyl-5α-cholest-7-enyl 3β-methoxymethyl ether. IC 50 of the compound inhibited the murine P388 tumor cell line was 2.3 μg/mL [311] . For the past decades, marine sponges have been considered as a very fertile field for the discovery of bioactive natural chemical substances with respect to the diversity of their primary and secondary chemical components and metabolites [312] . It was proved that marine sponges produce an enormous array of antitumor, antiviral, antiinflammatory, antibiotic, and other bioactive molecules that have the potential for therapeutic use. Studies showed that different components affect the targeted disease by different mechanisms. Natural chemical products that can act as inhibitors of transcription factors may be effective against both malignant neoplasms and viral diseases. Most bioactive metabolites from sponges proved to be inhibitors of certain enzymes, which often mediate or produce mediators of intracellular or intercellular messengers involved in the pathogenesis of a disease [313] . Here, we introduce several kinds of recently confirmed bioactive lead compounds isolated from marine sponge which pharmacological mechanisms were studied. Cytarabine (Fig. 15.1) is derived from the related marine natural products spongothymidine and spongouridine, nucleosides with a modified sugar moiety. These nucleosides were isolated from the Caribbean sponge Crypotethia crypta by Bergmann and Feeney in 1951 [314] . Cytarabine is mainly used in the treatment of acute myeloid leukemia and acute lymphocytic leukemia (ALL), where it is the backbone of induction chemotherapy [315] . Cytosine arabinoside interferes with the synthesis of DNA. Its mode of action is due to its rapid conversion into cytosine arabinoside triphosphate, which damages DNA when the cell cycle holds in the S phase (synthesis of DNA). The cells requiring DNA replication for mitosis are therefore most affected [315] . Cytosine arabinoside was also considered as inhibitor of both DNA and RNA polymerases and nucleotide reductases needed for DNA synthesis. As an antiviral agent, cytarabine was often used to inhibit deoxycytidine utilization. Due to the rapid deamination in the body into the inactive uracil derivative, cytarabine therefore is often given by continuous intravenous infusion [316] . Renieramycin G (Fig. 15. 2) was isolated from marine sponges Xestospongia and Cribrochalina [317] . A recent study demonstrated that Renieramycin G induced apoptosis via the p53-dependent pathway and inhibited the progression and metastasis of non-small cell lung cancer [318] . The minimal antiproliferative activity for members of the tetrahydroisoquinoline family possessing an amide carbonyl group at the C-21 position seems consistent compared to their C-21 cyano-or carbinolamine-containing relatives. The brominated alkaloid Isofistularin-3 (Iso-3), a new DNA methyltransferase (DNMT)1 inhibitor, was from the marine sponge Aplysina aerophoba [319] ( Fig. 15.3) . Docking analysis confirmed DNMT inhibition data in vitro and revealed binding of Iso-3 within the DNA binding site of DNMT1 [320] . Subsequent increased expression of tumor suppressor gene aryl hydrocarbon receptor (AHR) could be correlated to decreased methylation of CpG sites within the essential Sp1 regulatory region of its promoter. Iso-3 induced growth arrest of cancer cells in G0/ G1 with increasing p21 and p27 expression and reducing cyclin E1, PCNA and c-myc levels. Fluorescent and transmission electron microscopy revealed that the reduced proliferation was accompanied by morphological changes as autophagy. Furthermore, Iso-3 strongly synergized with tumor necrosis factor-related apoptosisinducing ligand (TRAIL) in RAJI [combination index (CI) = 0.22] and U937 cells (CI = 0.21) and increased TRAIL-induced apoptosis via a mechanism involving reduction of survivin expression but not of Bcl-2 family proteins nor X-linked inhibitor of apoptosis protein (XIAP) [321] . Treatment of Iso-3 decreased FLIPL expression and triggered activation of endoplasmic reticulum (ER) stress with increased GRP78 expression, which eventually induced TRAIL receptor death receptor (DR)5 surface expression. Importantly, as a potential candidate for further anticancer drug development, Iso-3 reduced the viability, colony, and in vivo tumor forming potential without affecting the viability of PBMCs from healthy donors or zebrafish development [321] . Ageladine A (Fig. 15.4) was derived from the sponge Agelas nakamurai [322] , exhibiting in vitro and in vivo antiangiogenic activity associated with its MMP inhibition. However, subsequent study confirmed that it is resulted from the selective inhibition of kinases such as yeast Sps1/Ste20-related kinase 4, dual specificity tyrosine-phosphorylation-regulated kinase 1A, and tyrosine kinase 2 [323] . Ageladine A and its synthetic analogues feature highly selective angiogenesis inhibition, at concentrations of which no cytotoxicity are shown in the National Cancer Institute (NCI) panel of 60 human cancer cell lines. Moreover, ageladine A is a fluorescent dye that is pH-sensitive and is of interest for imaging [324] . Naamidine A (Fig. 15 .5) was found in marine sponge Leucetta chagosensis. Bioactivity study showed that this compound inhibits the EGF signaling pathway and is more specific for the EGF-mediated mitogenic activity than for the insulinmediated mitogenic activity [325] . In 2009, LaBarbera et al. illustrated that naamidine A triggers biomarkers of apoptosis like externalization of phosphatidylserine, cleavage and activation of caspases-3, −8, and − 9, and disruption of the mitochondrial membrane potential indicating that the cell death caused by naamidine A in epidermoid carcinoma cells (A-431) is a consequence of apoptosis instead of cytotoxicity. It is also reported that naamidine A inhibits the growth of tumor xenograft by activating caspase-3 manifesting apoptosis activity in vivo. Besides, naamidine A-caused apoptosis does not depend on functional p53 and is independent of extracellular signal-regulated kinase 1/2 [326] . Araguspongine C (Fig. 15.6 ) is a group of macrocyclic oxaquinolizidine alkaloids derived from the marine sponge Xestospongia species [327] . Araguspongine C prevented the proliferation of varied breast cancer cell lines in vitro dosedependently. Characterized by vacuole formation and upregulation of autophagy markers such as Atg3, Atg7, Atg16L, and LC3A/B suppressing c-Met and HER2 receptor tyrosine kinase activation [328] , araguspongine C induces autophagic cell death in HER2-overexpressing BT-474 breast cancer cells. What's more, docking research and cell-free Z-LYTE assays revealed that araguspongine C owing the direct interaction potentially with the receptor tyrosine kinases c-Met and HER2 at their kinase domains. Especially, araguspongine C treatment causes the suppression of PI3K/Akt/mTOR signaling cascade in breast cancer cells by autophagy [328] . Psammaplysene A (Fig. 15.7) is derived from the marine sponge Psammaplysilla sp. Schroeder et al. demonstrated that psammaplysene A was an active inhibitor of a transcription factor FOXO1 nuclear export, whereas psammaplysene B shows less potential [329] . Extensive study illustrated that human endometrial cancer cells treated for 24 h with 1 μM psammaplysene A causes cell death leading to morphology changes with apoptosis and PARP cleavage, revealing that the cell death aroused from psammaplysene A is a result of apoptosis instead of cytotoxicity. Psammaplysene A bringing about the doubling of cells in the G2/M phase and FOXO1 silencing in ECC-1 cells reduces psammaplysene A-induced apoptosis [330] . Agelasines from a marine sponge Agelas clathrodes have structurally unique compounds which possess mono or bi-cyclic diterpenoids with a 9-methyladeninium chromophore. The cytotoxicity of agelasine B (Fig. 15.8 ) and its mechanism have been extensively studied which are of great interest that its higher toxicity in cancer cells (IC50 = 3.22, 2.99, and 6.86 μM MCF-7, SKBr3, and PC-3 cells, respectively) than in normal cells (fibroblasts, IC50 = 32.91 μM) where agelasine B upregulated the intracellular concentration of Ca 2+ and caused fast Ca 2+ release via the endoplasmic reticulum (ER). This research indicated that sarcoplasmic-ER Ca 2+ -ATPase activity is inhibited by agelasine B. What's more, intracellular Ca 2+ accumulation in the mitochondria is tied to apoptosis. In addition, this marine sponge toxin induces DNA fragmentation and severely enhances caspase-8 activity in MCF-7 cells [331] . Therefore, agelasine B is potential for treating breast cancer for less toxicity in normal breast cells. PM060184 (Fig. 15.9 ) belongs to a new family of tubulin-binding agents originally isolated from the marine sponge Lithoplocamia lithistoides [332] . It was published that PM060184 presents the highest known affinities among tubulin-binding agents and that it targets tubulin dimers at a new binding site. PM060184 has a potent antitumor activity in a panel of different tumor xenograft models. Moreover, PM060184 is able to overcome P-gp-mediated resistance in vivo, an effect that could be related to its high binding affinity for tubulin. PM060184 is an inhibitor of tubulin polymerization that reduces microtubule dynamicity in cells by 59% [333] . PM060184 suppresses microtubule shortening and growing at a similar extent. This action affects cells in interphase and mitosis. In the first case, the compound induced a disorganization and fragmentation of the microtubule network and the inhibition of cell migration. In the second case, it induced the appearance of multipolar mitosis and lagging chromosomes at the metaphase plate. These effects correlated with a nonclassical apoptosis pathway, which caused prometaphase arrest and induction of caspase-dependent apoptosis or appearance of cells in a multinucleated interphaselike state. Taken together, PM060184 represents a new tubulin-binding agent with promising potential as an anticancer agent [334] . Eribulin mesylate (E7389) (Fig. 15.10) is a microtubule dynamics inhibitor with antitumor activity, which is effective against not only a broad range of human cancer cell lines but also human tumor xenograft models derived from melanoma, colon, breast, ovarian, and pancreatic cancer [336] . This non-taxane molecule is a structurally simplified synthetic analogue of halichondrin B derived from the marine sponge Halichondria okadai [335] . Different from other tubulin-targeted agents like taxanes, epothilones, and vinca alkaloid, which affect both growth and shortening of microtubules, eribulin only affects growth by binding to the microtubules and suppressing microtubule polymerization without affecting shortening, thereby sequestering tubulin into nonfunctional aggregates [336, 337] . The prohibited formation of mitotic spindles leads to G2/M cell cycle arrest and apoptosis as a result of prolonged mitotic blockage. Eribulin remains to be active in taxane-resistant cell lines with β-tubulin mutations and those which overexpress P-gp according to in vitro studies. It's reported to be manageably safe in a 21-day-cycle administration, neutropenia being the main dose limit among all toxicities, with an MTD of 1.4 mg/m 2 in phase I studies, but seems to be both effective and safe in several phase II studies. Therefore, it has been applied to patients with locally advanced or metastatic breast cancer previously treated with at least two chemotherapeutic regimens for advanced disease [335] [336] [337] . 10-Acetylirciformonin B (Fig. 15 .11) classified as furanoterpenoid which is isolated from marine sponge Ircinia sp. can restrain the growth of leukemia HL-60 cells, with an IC50 value of 1.7 μg/mL obtained at 48 h of treatment due to its unique structure of the linear C22-sesterterpenoid. What's more, its anticancer activity was activated by inducting of DNA damage and apoptosis. To be detailed, DNA damage was mediated by the phosphorylation of histone H2AX, p-CHK2 (checkpoint kinase), sensitive markers of DNA double-strand breaks (DSBs), and apoptosis which was triggered by caspase-8, caspase-9, and caspase-3, resulting to PARP cleavage, the downregulation of Bcl-xL and the upregulation of Bax [338] . Hyrtioreticulins A and B (Fig. 15 .12) belong to indole alkaloids derived from the marine sponge Hyrtios reticulatus. These alkaloids have inhibition of E1-ubiquitin intermediate formation from 0.75 to 11 μg/mL in IC50 values [339] . Moreover, the structures are approximately the same except for their stereochemistry at C-1, in which hyrtioreticulin A is trans-configured and hyrtioreticulin B is cis, respectively, demonstrating that the trans configuration reinforces inhibitory activity against E1, the ubiquitin-activating enzyme required for ubiquitination in the ubiquitinproteasome pathway involving in a large variety of cellular events such as cell cycle control, transcription, and development [340] . Deregulation of this pathway, therefore, can cause numerous diseases like cancer. Consequently, the ubiquitin pathway plays a significant role in anticancer drugs. In that context, hyrtioreticulins A and B catch more attention on the bioactivity on new anticancer therapeutics. Peloruside A (Fig. 15.13) is a microtubule-stabilizing agent isolated from a New Zealand marine sponge [341] . Peloruside prevents growth of a panel of cancer cell lines at low nanomolar concentrations, including cell lines that are resistant to paclitaxel. Three xenograft studies in athymic nu/nu mice were performed to assess the efficacy of peloruside compared with standard anticancer agents such as paclitaxel, docetaxel, and doxorubicin. In the first study, peloruside A, 5 and 10 mg/kg (QD × 5) caused growth inhibition (%TGI of 84% and 95%, respectively), on the growth of H460 non-small cell lung cancer xenografts, whereas standard treatments with paclitaxel (8 mg/kg, QD × 5) and docetaxel (6.3 mg/kg, Q2D × 3) were much less effective (%TGI of 50% and 18%, respectively). In a second xenograft study using A549 lung cancer cells and varied schedules of dosing, activity of peloruside was again superior compared with the taxanes with inhibitions ranging from 51% to 74%, compared with 44% and 50% for the two taxanes [342] . A third xenograft study in a P-glycoprotein-overexpressing NCI/ADR-RES breast tumor model showed that peloruside was better tolerated than either doxorubicin or paclitaxel. Peloruside is highly effective in preventing the growth of lung and P-glycoproteinoverexpressing breast tumors in vivo and that further therapeutic development is necessary [343] . E7974 (Fig.15 .14) is a synthetic analogue of the marine sponge natural product hemiasterlin. Hemiasterlin, a potent cytotoxic tripeptide, was originally isolated from marine sponges [344] . E7974 acts via a tubulin-based antimitotic mechanism. E7974 inhibits polymerization of purified tubulin in vitro with IC 50 values similar to those of vinblastine. In cultured human cancer cells, E7974 induces G 2 /M arrest and marked disruption of mitotic spindle formation. Consistent with this observation, E7974 induces caspase-3 activation and PARP cleavage, typical biochemical markers of apoptosis. Only a short cellular exposure to E7974 is sufficient to induce maximum mitotic arrest, suggesting that E7974's antitumor effects in vivo may persist even after blood levels of the drug decrease after drug administration. Investigation of interactions of E7974 with purified tubulin using two synthetic tritiated photoaffinity analogues of E7974 indicated that E7974 seems to share a unique, predominantly α-tubulin-targeted mechanism with other hemiasterlin-based compounds, suggesting the hemiasterlins evolved to mainly target α-tubulin, not β-tubulin subunits unlike many tubulin-targeted natural products [345] . Phorbaketal A (Fig. 15.15 ) is a metabolite of the marine sponge Phorbas sp. [346] . This tricyclic sesterterpenoid has significant inhibitory effect on the production of nitric oxide (NO) and inflammatory cytokines such as tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, and monocyte chemotactic protein-1 which is induced by inhibited the transcription of a crucial signaling molecule named nuclear factor-kap-paB (NF-κB) in inflammation, whereas the expression of heme oxygenase-1 (HO-1) proved to be upregulated in LPS-stimulated RAW 264.7 cells [347] . Solomonsterol A (Fig. 15.16) , a selective pregnane X receptor (PXR) agonist found in the marine sponge Theonella swinhoei, shows anti-inflammatory activity and immune dysfunction and attenuates systemic inflammation in the rheumatoid arthritis mouse model. It is reported that solomonsterol A had an effect on protecting from the development of arthritis according to arthritis score, CRP, and plasma cytokines. In addition, anti-collagen antibodies (CAIA) could reduce the expression of inflammatory markers including TNFα, IFNγ, and IL-17 and chemokines MIP1α and RANTES in draining lymph nodes in the rheumatoid arthritis mouse model which are induced by injecting transgenic mice harboring a humanized PXR [348] . Epimuqubilin A (Fig. 15.17) , a norsesterterpene peroxide isolated from marine sponge Latrunculia sp., inhibits nitric oxide production in LPS-stimulated RAW 264.7 cells (IC(50) = 7.6 μM). At both the mRNA and protein levels, cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) are suppressed in a dosedependent manner. Mitogen-activated protein kinases (MAPKs), one major upstream signaling pathway involved in the transcription of both COX-2 and iNOS, were not affected by treatment of epimuqubilin A. However, the compound blocked the phosphorylation of inhibitor κB (IκB) kinase (IKKβ), resulting in the stabilization of IκBα and inhibition of NF-κB p65 nuclear translocation and DNA binding. Levels of phosphorylated IKKα were not affected. This is an unique mechanistic relationship that suggests epimuqubilin A warrants further exploration as a potential therapeutic agent [349] . Ascididemin (ASC) is a marine alkaloid and belongs to the group of pyridoacridine alkaloids, mostly being isolated from sponges and tunicates (Fig. 15.18 [350, 351] . Similar to other planar pyridoacridine derivatives, ascididemin interacts with DNA and recognizes triplex and quadruplex structures especially G-quadruplexes. Different mechanisms of action for this alkaloid have been proposed including topoisomerase I and II toxins. However, experiments with cell lines resistant to these toxins indicated that topo I and II are not potential targets for ascididemin (ASC) in the cell but may be by reactive oxygen species (ROS) to cleave DNA. Own work contributes to its action on the apoptotic signaling in Jurkat leukemia cells. Interestingly, ACS induces a mitochondrial pathway that requires the activation of caspase-2 upstream of mitochondria. Caspase-2 activation was not blocked by the overexpression of Bcl-2 proteins such as Bcl-xL and was responsible for caspase-9 activation. As a possible link between caspase-2 and mitochondrial activation, Bid was found to be cleaved by ASC as a specific caspase-2 inhibitor inhibits the ASC-induced cleavage of Bid [351] . In addition, JNK was activated by ASC upstream of mitochondria via reactive oxygen species. Caspase-2 activation provides a possible link between the DNA damaging activity and the induction of apoptosis. To this end, ASC might be a valuable chemical tool to induce DNA damage and apoptotic signaling events. Variolin B (VAR-B) (Fig. 15.19 ) is a natural product isolated from the sponge Kirkpatrickia variolosa, found in Antarctica. VAR-B has been shown potent proapoptotic activity. In different human cancer cell lines, both compounds inhibited colony formation, caused cell cycle arrest, and induced apoptosis at concentrations ranging from 0.1 to 2 μM. Although variolins induced an increase in the levels of p53 with an increase in p21, their cytotoxicities did not appear to be dependent on p53 status as their potency was comparable in cells with wild-type p53 or in sublines with inactivated p53. Both VAR-B and dVAR-B prevent the cells from enter- ing S phase, blocking cells in G1 and cause an accumulation of cells in G2. The apoptosis induced by VAR-B and dVAR-B occurred very rapidly in some cell lines (e.g., Jurkat leukemia cells) and was already evident 4 h after the beginning of treatment. Although intercalation of dVAR-B in DNA has been demonstrated, neither VAR-B nor dVAR-B produces detectable breaks in DNA, which are consistent with the in vitro biochemical assays that also demonstrated that dVAR-B is not topoisomerase I or II poison. Instead, each of these variolins appears to inhibit cyclindependent kinases (CDKs) in the lM range. CDK1-cyclin B, CDK2-cyclin A, and CDK2/cyclin E complexes were inhibited in a range of concentrations lower than those required to inhibit the activity of CDK4/cyclin D or CDK7/cyclin H complexes. Variolins are a new class of CDK inhibitors that activate apoptosis in a p53-independent fashion, and thus they may be effective against tumors with p53 mutations or deletions [352] . Spongistatin is a macrocyclic lactone that has been isolated from the marine sponges Spirastrella spinispirulifera and Hyrtios sp. by the group of Pettit. Spongistatin 1 (Fig. 15.20) showed interesting apoptotic features in various tumor cells. In leukemic cell lines, it triggered caspase-dependent apoptosis through the release of cytochrome c, Smac/Diablo, and Omi/HtrA2 from the mitochondria into the cytosol. Spongistatin 1 caused degradation of the anti-apoptotic XIAP, which suggested it might be a promising drug for the treatment of chemoresistance due to overexpression of XIAP. Moreover spongistatin 1 induces apoptosis more efficiently in human primary leukemic cells of children suffering from acute leukemia at low nanomolar concentrations than clinically applied conventional drugs used in micromolar concentrations. In addition normal healthy peripheral blood cells were significantly less affected by spongistatin 1 [353] . Besides leukemic cells, spongistatin 1 showed promising apoptotic potential in mammary cancer cells including the treatment-resistant cell line MCF-7 lacking caspase-3. Regarding the apoptotic signaling pathways of spongistatin 1, two interesting features can be reported. First, spongistatin 1-induced cell death involves the pro-apoptotic proteins AIF and endonuclease G. Both proteins translocate from mitochondria to the nucleus and contribute to spongistatin 1-mediated apoptosis as shown via gene silencing. Second, spongistatin 1 acts as a tubulin-depolymerizing agent and is able to free the pro-apoptotic Bcl-2 family member Bim from its sequestration both by the microtubular complex and by the anti-apoptotic protein Mcl-1. Silencing of Bim by siRNA leads to a diminished translocation of AIF and endonuclease G to the nucleus and subsequently reduces rate of apoptosis. By using spongistatin 1 as a chemical tool, Bim has been suggested to be an important factor upstream of mitochondria by executing a central role in the caspase-independent apoptotic signaling pathway induced by spongistatin 1. These different apoptotic features indicate that the apoptosis signaling is cell line-specific. Finally, spongistatin 1 affects highly invasive pancreatic tumor cells by not only inhibiting their invasion and migration but also by inducing anoikis in these cells. Bcl-2 seems to be a major target for spongistatin 1 in these processes. Besides tumor cells, spongistatin inhibits angiogenic activity of endothelial cells via inhibition of PKC-a [354] . An alkaloid protein kinase C inbibitor, xestocyclamine A, from the marine sponge Xestospongia sp Novel marine sponge alkaloids:V. an alkaloid protein kinase C inhibitor, xestocyclamine A, from the marine sponge Xestospongia sp Naturally occurring somatostatin and vasoactive intestinal peptide inhibitors. Isolation of alkaloids from two marine sponges Mauritiamine, a new antifouling oroidin dimer from the marine sponge Agelas mauritiana Isolation and X-ray crystal structure of racemic Xestospongin D from the Singapore marine sponge Niphates sp Soest: bioactive pyridoacridine alkaloids from the micronesian sponge Oceanapia sp Halitulin, a new cytotoxic alkaloid from the marine sponge Haliclona tulearensis A new discorhabdin from two sponge genera Plakinamines C and D and three other new steroidal alkaloids from the sponge Corticium sp New bisindole alkaloids of the topsentin and hamacanthin classes from the Mediterranean marine sponge Rhaphisia lacazei Dragmacidin F: a new antiviral bromoindole alkaloid from the Mediterranean sponge Halicortex sp Makaluvamine P, a new cytotoxic pyrroloiminoquinone from Zyzzya cf. fuliginosa Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1) Antibacterial activity against resistant bacteria and cytotoxicity of four alkaloid toxins isolated from the marine sponge Arenosclera brasiliensis New and biologically active imidazole alkaloids from two sponges of the genus Leucetta Manadomanzamines A and B: a novel alkaloid ring system with potent activity against mycobacteria and HIV-1 Brominated pyrrole alkaloids from marine Agelas sponges reduce depolarization-induced cellular calcium elevation 8-Hydroxymanzamine A, a β-carboline alkaloid from a sponge Pachypellina sp New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases Neuritogenic activity-guided isolation of a free base form manzamine A from a marine sponge, Acanthostrongylophora aff. ingens 3,4-dihydro-6-hydroxy-10,11-epoxymanzamine A, and 3,4-dihydromanzamine J N-oxide, new manzamine alkaloids from sponge Amphimedon sp Cytotoxic pyrroloiminoquinones from four new species of south African latrunculid sponges Enantiomeric discorhabdin alkaloids and establishment of their absolute configurations using theoretical calculations of electronic circular dichroism spectra Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya sp Sesterterpenoids and an alkaloid from a Thorectandra sp. as inhibitors of the phosphatase Cdc25B Cytotoxic bisindole alkaloids from a marine sponge Spongosorites sp Antimicrobial activity and cytotoxicity of bis (indole) alkaloids from the sponge Spongosorites sp angiogenic steroidal alkaloids, from the marine sponge Corticium simplex Ircinamine B, bioactive alkaloid from marine sponge Dactylia sp Psammaplysenes C and D, cytotoxic alkaloids from Psammoclemma sp Cytotoxic alkylpiperidine alkaloids from the Brazilian marine sponge Pachychalina alcaloidifera Neopetrosiamine A, biologically active bis-piperidine alkaloid from the Caribbean Sea sponge Neopetrosia proxima The in vivo antiplasmodial activity of haliclonacyclamine A, an alkaloid from the marine sponge Haliclona sp Batzelladine alkaloids from the caribbean sponge Monanchora unguifera and the significant activities against HIV-1 and AIDS opportunistic infectious pathogens Bioactive guanidine alkaloids from two Caribbean marine sponges Antiparasitic guanidine and pyrimidine alkaloids from the marine sponge Monanchora arbuscula Disturbance of voltage-induced cellular calcium entry by marine dimeric and tetrameric pyrrole-imidazole alkaloids A new cyclostellettamine from sponge Amphimedon compressa Njaoaminiums A, B, and C: cyclic 3-alkylpyridinium salts from the marine sponge Reniera sp New bioactive bromotyrosine-derived alkaloid from a marine sponge Aplysinella sp Trachycladindoles A-G: cytotoxic heterocycles from an Australian marine sponge, Trachycladus laevispirulifer Nagelamides Q and R, novel dimeric bromopyrrole alkaloids from sponges Agelas sp Benzosceptrin C, a new dimeric bromopyrrole alkaloid from sponge Agelas sp Ecionines A and B, two new cytotoxic pyridoacridine alkaloids from the Australian marine sponge, Ecionemia geodides A bastadin with potent and selective δ-opioid receptor binding affinity from the Australian sponge Ianthella flabelliformis Baculiferins A-O, O-sulfated pyrrole alkaloids with anti-HIV-1 activity, from the Chinese marine sponge Iotrochota baculifera Monanchocidin: A new apoptosis-inducing polycyclic guanidine alkaloid from the marine sponge Monanchora pulchra Ceratinadins A-C, new bromotyrosine alkaloids from an Okinawan marine sponge Pseudoceratina sp Antimalarial bromotyrosine derivatives from the Australian marine sponge Hyattella sp Psammaplysin H, a new antimalarial bromotyrosine alkaloid from a marine sponge of the genus Pseudoceratina Guanidine alkaloids from Monanchora arbuscula: chemistry and antitumor potential Monanchocidins B-E: polycyclic guanidine alkaloids with potent antileukemic activities from the sponge Monanchora pulchra Monanchomycalins A and B, unusual guanidine alkaloids from the sponge Monanchora pulchra Pseudoceramines A-D, new antibacterial bromotyrosine alkaloids from the marine sponge Pseudoceratina sp New bioactive alkaloids from the marine sponge Stylissa sp Densanins A and B, new macrocyclic pyrrole alkaloids isolated from the marine sponge Haliclona densaspicula Pentacyclic ingamine alkaloids, a new antiplasmodial pharmacophore from the marine sponge Petrosid Ng5 Sp5 halogenated alkaloids from the sponge Iotrochota purpurea with antibiotic activity and regulation of tyrosine kinases Heteroaromatic alkaloids, nakijinamines, from a sponge Suberites sp Antimicrobial metabolites from the Paracel Islands sponge Agelas mauritiana Thiaplakortones A-D: antimalarial thiazine alkaloids from the Australian marine sponge Plakortis lita Allos-hemicalyculin A, a photochemically converted calyculin from the marine sponge Discodermia calyx Pyrinodemins G-I, new bis-3-alkylpyridine alkaloids from a marine sponge Amphimedon sp Nagelamides X-Z, dimeric bromopyrrole alkaloids from a marine sponge Agelas sp Nagelamides U-W, bromopyrrole alkaloids from a marine sponge Agelas sp Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor N-containing metabolites from the marine sponge Agelas clathrodes Aaptamines, marine spongean alkaloids, as anti-dormant mycobacterial substances Three new aaptamine derivatives from the South China Sea sponge Aaptos aaptos Netamines O-S, five new tricyclic guanidine alkaloids from the Madagascar sponge Biemna laboutei and their antimalarial activities New indole alkaloids from the sponge Plakortis sp Bioactive isoquinolinequinone alkaloids from the South China Sea nudibranch Jorunna funebris and its sponge-prey Xestospongia sp Antipodal crambescin A2 homologues from the marine sponge Pseudaxinella reticulata. Antifungal structure-activity relationships Bioactive alkaloids from the Red Sea marine Verongid sponge Pseudoceratina arabica Haliclonadiamine derivatives and 6-epi-Monanchorin from the marine sponge Halichondria panicea collected at Iriomote Island additional inhibitors of protein phosphatases 1 and 2a, from the marine sponge discodermia calyx Cytotoxic peptides from the marine sponge Cymbastela sp Halicylindramides D and E, antifungal peptides from the marine sponge Halichondria cylindrata Koshikamide A 1, a new cytotoxic linear peptide isolated from a marine sponge, Theonella sp Pseudotheonamides, serine protease inhibitors from the marine sponge Theonella swinhoei Miraziridine A, a novel cysteine protease inhibitor from the marine sponge Theonella aff. mirabilis 1 Dysinosin A: a novel inhibitor of factor VIIa and thrombin from a new genus and species of Australian sponge of the family Dysideidae Dysinosins BD, inhibitors of factor VIIa and thrombin from the Australian sponge Lamellodysidea chlorea Kendarimide A, a novel peptide reversing P-glycoprotein-mediated multidrug resistance in tumor cells, from a marine sponge of Haliclona sp Polytheonamides A and B, highly cytotoxic, linear polypeptides with unprecedented structural features, from the marine sponge, Theonella swinhoei Polytheonamides, unprecedented highly cytotoxic polypeptides from the marine sponge Theonella swinhoei 2. Structure elucidation A cytotoxic peptide from a marine sponge exhibits ion channel activity through vectorial-insertion into the membrane Polytheonamides, unprecedented highly cytotoxic polypeptides, from the marine sponge theonella swinhoei: 1. Isolation and component amino acids Solution structure of polytheonamide B, a highly cytotoxic nonribosomal polypeptide from marine sponge Koshikamide A2, a cytotoxic linear undecapeptide isolated from a marine sponge of Theonella sp Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells Yaku'amides A and B, cytotoxic linear peptides rich in dehydroamino acids from the marine sponge Ceratopsion sp Aciculitins A-C: cytotoxic and antifungal cyclic peptides from the lithistid sponge Aciculites orientalis Improved total synthesis and structure-activity relationship of arenastatin A, a potent cytotoxic spongean depsipeptide An antifungal cyclodepsipeptide, Cyclolithistide A, from the sponge Theonella swinhoei Cyclotheonamides E2 and E3, new potent serine protease inhibitors from the marine sponge of the genus Theonella Homophymine A, an anti-HIV cyclodepsipeptide from the sponge Homophymia sp Homophymines B-E and A1-E1, a family of bioactive cyclodepsipeptides from the sponge Homophymia sp Jaspamides M-P: new tryptophan modified jaspamide derivatives from the sponge Jaspis splendens New Jaspamide derivatives from the marine sponge Jaspis splendans collected in Vanuatu Two new jaspamide derivatives from the marine sponge Jaspis splendens The kapakahines, cyclic peptides from the marine sponge Cribrochalina olemda new cyclic peptides containing an oxazole or a thiazole ring from a Theonella sponge Keramamide F, a new thiazole-containing peptide from the Okinawan marine sponge Theonella sp Microsclerodermins F-I, antitumor and antifungal cyclic peptides from the lithistid sponge Microscleroderma sp Motuporin, a potent protein phosphatase inhibitor isolated from the Papua New Guinea sponge Theonella swinhoei Gray Neosiphoniamolide A, a novel cyclodepsipeptide, with antifungal activity from the marine sponge Neosiphonia superstes Orbiculamide A: a novel cytotoxic cyclic peptide from a marine sponge Theonella sp Perthamides C-F, potent human antipsoriatic cyclopeptides Anti-inflammatory cyclopeptides from the marine sponge Theonella swinhoei Antineoplastic agents. 193. Isolation and structure of the cyclic peptide hymenistatin 1 Antineoplastic agents. 219. Isolation and structure of the cell growth inhibitory constituents from the western Pacific marine sponge Axinella sp Antineoplastic agents. 279. Isolation and structure of axinastatin 4 from the western Indian Ocean marine sponge Axinella cf. carteri Hymenamides A and B, new proline-rich cyclic heptapeptides from the Okinawan marine sponge Hymeniacidon sp Isolation and structure of the marine sponge cell growth inhibitory cyclic peptide phakellistatin 1 Antineoplastic agents. 400. Synthesis of the Indian Ocean marine sponge cyclic heptapeptide Phakellistatin 2 Antineoplastic agents. 303. Isolation and structure of the human cell growth inhibitory phakellistatin 4 from the western Pacific sponge Phakellia costata Antineoplastic agents 315. Isolation and structure of the marine sponge cancer cell growth inhibitor phakellistatin 5 Cyclopeptide compound phakellistatin 12 having antitumor activity. CN1396177A Total synthesis of a marine cyclic peptide: phakellistatin-13 Proline-containing cyclopeptides from the marine sponge Phakellia fusca Reniochalistatins A-E, cyclic peptides from the marine sponge Reniochalina stalagmitis Phormidolides B and C, cytotoxic agents from the sea: enantioselective synthesis of the macrocyclic core Structure and absolute stereochemistry of Phormidolide, a new toxic metabolite from the marine Cyanobacterium Phormidium sp Gracilioethers A−C, antimalarial metabolites from the marine sponge Agelas gracilis Discovery of a new class of marine ligands of peroxisome proliferator-activated receptor γ Gracilioethers E-J, new oxygenated polyketides from the marine sponge Plakinastrella mamillaris Oxygenated polyketides from Plakinastrella mamillaris as a new chemotype of PXR agonists Smenamides A and B, chlorinated peptide/polyketide hybr,ids containing a dolapyrrolidinone unit from the Caribbean sponge Smenospongia aurea. Evaluation of their role as leads in antitumor drug research New antimalarial polyketide endoperoxides from the marine sponge Plakinastrella mamillaris collected at Fiji Islands Manzamenones L-N, new dimeric fatty-acid derivatives from an Okinawan marine sponge Plakortis sp Tedanolide: a potent cytotoxic macrolide from the Caribbean sponge Tedania ignis Bioactive marine metabolites: IIIV. Cytotoxic metabolites of the marine sponge Mycale adhaerens Lambe Tedanolide C: a potent new 18-membered-ring cytotoxic macrolide isolated from the Papua New Guinea marine sponge Ircinia sp New Candidaspongiolides, tedanolide analogues that selectively inhibit melanoma cell growth Structure-activity relationship study on 13-deoxytedanolide, a highly antitumor macrolide from the marine sponge Mycale adhaerens Myriaporones 1−4, cytotoxic metabolites from the Mediterranean Bryozoan Myriapora truncate 13-Deoxytedanolide, a marine sponge-derived antitumor macrolide, binds to the 60S large ribosomal subunit Induction of apoptosis in human cancer cells by candidaspongiolide, a novel sponge polyketide Lehualides E−K, cytotoxic metabolites from the tongan marine sponge Plakortis sp Lehualides A−D, metabolites from a Hawaiian sponge of the genus Plakortis Franklinolides A-C from an Australian marine sponge complex: phosphodiesters strongly enhance polyketide cytotoxicity Bitungolides A−F, new polyketides from the Indonesian sponge Theonella cf. swinhoei New bioactive halenaquinone derivatives from South Pacific marine sponges of the genus Xestospongia Marine sponge polyketide inhibitors of protein tyrosine kinase Protein tyrosine kinase inhibitory properties of planar polycyclics obtained from the marine sponge Xestospongia cf. carbonaria and from total synthesis New Pentacyclic compounds from the Okinawan marine sponge Xestospongia sapra Absolute stereostructures of halenaquinol and halenaquinol sulfate, pentacyclic hydroquinones from the okinawan marine sponge xestospongia sapra, as determined by theoretical calculation of CD spectra Xesto-and halenaquinone derivatives from a sponge, Adocia sp., from Truk lagoon Halenaquinone and xestoquinone derivatives, inhibitors of Cdc25B phosphatase from a Xestospongia sp Metabolites from the sponge Plakortis simplex. Determination of absolute stereochemistry of plakortin isolation and stereostructure of three plakortin related compounds Activity against plasmodium falciparum of cycloperoxide compounds obtained from the sponge Plakortis simplex Plakortides I-L, four new cyclic peroxides from an undescribed Jamaican sponge Plakortis sp. (Homosclerophorida, Plakinidae) Plakortides M and N, bioactive polyketide endoperoxides from the Caribbean marine sponge Plakortis halichondrioides Antifungal peroxyketal acids from an Okinawan marine sponge of Plakortis sp Manadoperoxides A−D from the Indonesian sponge Plakortis cfr. simplex. Further insights on the structure−activity relationships of simple 1,2-dioxane antimalarials Endoperoxide derivatives from marine organisms: 1,2-Dioxanes of the plakortin family as novel antimalarial agents Cytotoxic polyketides from the marine sponge Discodermia calyx A revised structure of pederin Mycalamide A, an antiviral compound from a New Zealand sponge of the genus Mycale Isolation and structure elucidation of onnamide A, a new bioactive metabolite of a marine sponge, Theonella sp Antiviral and antitumor agents from a New Zealand sponge, Mycale sp. 2. Structures and solution conformations of mycalamides a and B Bioactive marine metabolites. 41. Theopederins A-E, potent antitumor metabolites from a marine sponge, Theonella sp Eight new cytotoxic metabolites closely related to onnamide A from two marine sponges of the genus Theonella Theopederins F-J: five new antifungal and cytotoxic metabolites from the marine sponge, theonella swinhoei 1 Mycalamides C and D, cytotoxic compounds from the marine sponge Stylinos n. species Mycalamide D, a new cytotoxic amide from the New Zealand marine sponge Mycale Species Onnamide F: a new nematocide from a southern Australian marine sponge. Trachycladus laevispirulifer Theopederins K and L. highly potent cytotoxic metabolites from a marine sponge Discodermia Species Bioactive marine metabolites: XVI. Calyculin A. A novel antitumor metabolite from the marine sponge Discodermia calyx Isolation and structure elucidation of calyculins B, C, and D, novel antitumor metabolites, from the marine sponge Discodermia calyx Isolation of four new calyculins from the marine sponge Discodermia calyx 1 Isolation of dephosphonocalyculin a from the marine sponge, Discodermia calyx Insight into binding of Calyculin A to protein phosphatase 1: isolation of hemicalyculin A and chemical transformation of Calyculin A Spongederived fijianolide polyketide class: further evaluation of their structural and cytotoxicity properties polyketide heterocycles from a marine sponge New potent cytotoxic macrolides from a marine sponge and a nudibranch predator New cytotoxic macrolides from the sponge Fasciospongia rimosa Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents Synthesis and biological evaluation of (−)-laulimalide analogues The marine sponge Plakortis zyggompha: a source of original bioactive polyketides Spiculoic acids A and B, new polyketides isolated from the Caribbean marine sponge Plakortis angulospiculatus Iso-, Nor-, and dinor-spiculoic acids A, polyketides from the marine sponge Plakortis zyggompha New pentacyclic polyketide dimeric peroxides from a Taiwanese marine sponge Petrosia elastica Participation of the β-hydroxyketone part for potent cytotoxicity of callystatin A, a spongean polyketide Halichondrins -antitumor polyether macrolides from a marine sponge Halichondramide, an antifungal macrolide from the sponge halichondria sp Macrocyclic antifungal metabolites from the Spanish dancer nudibranch Hexabranchus sanguineus and sponges of the genus Halichondria Mycalolides A -C, hybrid macrolides of ulapualides and halichondramide, from a sponge of the genus Mycale New Cytotoxic Macrolides from the Okinawan Sponge Jaspis sp Structure of swinholide-a, a new macrolide from the marine sponge theonella swinhoei Structure of swinholide A, a potent cytotoxic macrolide from the Okinawan marine sponge theonella swinhoei Absolute stereostructure of swinholide A, a potent cytotoxic macrolide from the Okinawan marine sponge Theonella swinhoei Marine natural products. XXIII.: Three new cytotoxic dimeric macrolides, Swinholides B and C and Isoswinholide A, congeners of Swinholide A, from the Okinawan marine sponge Theonella swinhoei Altohyrtin A, a potent anti-tumor macrolide from the Okinawan marine sponge Hyrtios altum Altohyrtins B and C and 5-desacetylaltohyrtin A, potent cytotoxic macrolide congeners of altohyrtin A, from the Okinawan marine sponge Hyrtios altum Isolation and structure of halistatin 1 from the eastern Indian Ocean marine sponge Phakellia carteri Cinachyrolide A: a potent cytotoxic macrolide possessing two spiro ketals from marine sponge Cinachyra sp Superstolide A: a potent cytotoxic macrolide of a new type from the new Caledonian deep water marine sponge Neosiphonia superstes A novel cytotoxic macrolide, Superstolide B, related to Superstolide A, from the new Caledonian marine sponge Neosiphonia superstes Reidispongiolide A and B, two new potent cytotoxic macrolides from the new caledonian sponge Reidispongia coerulea Lasonolide A, a new cytotoxic macrolide from the marine sponge Forcepia sp Isohomohalichondrin B, a new antitumour polyether macrolide from the New Zealand deep-water sponge Lissodendoryx sp Phorboxazoles A and B: potent cytostatic macrolides from marine sponge Phorbas species The mode of rabbit platelet shape change and aggregation induced by theonezolide-A, a novel polyketide macrolide, isolated from the Okinawan marine sponge Theonella sp Leucascandrolide A, a new type of macrolide: the first powerfully bioactive metabolite of calcareous sponges (Leucascandra caveolata, a new genus from the coral sea) Leucascandrolide B, a new 16-membered, extensively methyl-branched polyoxygenated macrolide from the Calcareous sponge Leucascandra caveolata from northeastern waters of New Caledonia Antitumor polyether macrolides: new and hemisynthetic Halichondrins from the New Zealand deep-water sponge Lissodendoryx sp Salicylihalamides A and B, novel cytotoxic macrolides from the marine sponge Haliclona sp Thiomycalolides: new cytotoxic trisoxazole-containing macrolides isolated from a marine sponge Mycale sp Isolation and structures of haterumalides NA, NB, NC, ND, and NE, novel macrolides from an Okinawan sponge Ircinia sp Chondropsins A and B: novel tumor cell growth-inhibitory macrolide lactams from the marine sponge Chondropsis sp New chondropsin macrolide lactams from marine sponges in the genus Ircinia Chondropsin D, a new 37-membered-ring macrolide lactam from the marine sponge Chondropsis Species Peloruside A: a potent cytotoxic macrolide isolated from the New Zealand marine sponge Mycale sp Peloruside B, a potent antitumor macrolide from the New Zealand marine sponge Mycale hentscheli: isolation, structure, total synthesis, and bioactivity Dactylolide, a new cytotoxic macrolide from the Vanuatu sponge Dactylospongia sp Isolation of a new mycalolide from the marine sponge Mycale izuensis Cytotoxic macrolides from a new species of the deep-water marine sponge Leiodermatium Hurghadolide A and Swinholide I, potent actin-microfilament disrupters from the Red Sea sponge Theonella swinhoei Neopeltolide, a macrolide from a lithistid sponge of the family Neopeltidae Structural assignment of Poecillastrins B and C, macrolide lactams from the deep-water Caribbean sponge Poecillastra Species Mirabilin, an antitumor macrolide lactam from the marine sponge Siliquariaspongia mirabilis Salarins A and B and tulearin A: new cytotoxic sponge-derived macrolides Antitumour polyether macrolides: four new halichondrins from the New Zealand deep-water marine sponge Lissodendoryx sp Leiodermatolide, a potent antimitotic macrolide from the marine sponge Leiodermatium sp Kabiramides J and K, trisoxazole macrolides from the sponge Pachastrissa nux Kabiramide L, a new antiplasmodial trisoxazole macrolide from the sponge Pachastrissa nux Callyspongiolide, a cytotoxic macrolide from the marine sponge Callyspongia sp Terpenoids with antifouling activity against barnacle larvae from the marine sponge Acanthella cavernosa Stereochemical evaluation of sesquiterpene quinones from two sponges of the genus Dactylospongia and the implication for enantioselective processes in marine terpene biosynthesis Sesquiterpene benzoxazoles and sesquiterpene quinones from the marine sponge Dactylospongia elegans Halichonadins G-J, new sesquiterpenoids from a sponge Halichondria sp Dysidavarones A-D, new sesquiterpene quinones from the marine sponge Dysidea avara Euryspongins A-C, three new unique sesquiterpenes from a marine sponge Euryspongia sp Isolation and cytotoxic evaluation of marine sponge-derived norterpene peroxides Cytotoxic pyrrolo and furanoterpenoids from the sponge Sarcotragus species New cytotoxic spongian diterpenes from the sponge Dysidea cf. arenaria 15-diene, a new antimalarial isonitrile diterpene from the sponge Ciocalapata sp Structural variations to the 9-N-methyladeninium diterpenoid hybrid commonly isolated from Agelas sponges New cytotoxic spongian-class rearranged diterpenes from a marine sponge The nitrogenous hamigerans: unusual amino acid-derivatized aromatic diterpenoid metabolites from the New Zealand marine sponge Hamigera tarangaensis new protein tyrosine phosphatase 1B inhibitors, from the marine sponge Strongylophora strongilata collected at Iriomote Island Strongylophorines, meroditerpenoids from the marine sponge Petrosia corticata, function as proteasome inhibitors Novel bishomoscalarane sesterterpenes from the sponge Phyllospongia foliascens 25-Deoxycacospongionolide B and cacospongionolide C, two new terpenoids from the sponge Fasciospongia cavernosa Cytotoxic scalarane sesterterpenes from a sponge, Hyrtios erecta Novel sesterterpenoid and norsesterterpenoid RCE-protease inhibitors isolated from the marine sponge Hippospongia sp Sesterterpenes and a new sterol from the marine sponge Phyllospongia foliascens Sesterterpenes from the tropical sponge Coscinoderma sp Scalarane Sesterterpenes from the sponge Hyatella sp Hippolides A-H, acyclic manoalide derivatives from the marine sponge Hippospongia lachne Phorbasones A and B, sesterterpenoids isolated from the marine sponge Phorbas sp. and induction of osteoblast differentiation Phorone A and isophorbasone A, sesterterpenoids isolated from the marine sponge Phorbas sp Sesterterpenoids isolated from a northeastern Pacific Phorbas sp Cytotoxic scalarane sesterterpenes from a Korean marine sponge Psammocinia sp Bioactive sesterterpenoids from a Korean sponge Monanchora sp Scalarane sesterterpenes from Thorectidae sponges as inhibitors of TDP-43 nuclear factor Scalarane sesterterpenes from the Egyptian Red Sea sponge Phyllospongia lamellosa Additional sesterterpenes and a nortriterpene saponin from the sponge Clathria gombawuiensis Globostelletins A-I, cytotoxic isomalabaricane derivatives from the marine sponge Rhabdastrella globostellata Steroidal alkaloids from the marine sponge Corticium niger that inhibit growth of human colon carcinoma cells Amaranzole A, a new N-imidazolyl steroid from Phorbas amaranthus Acetylcholinesterase-inhibiting steroidal alkaloid from the sponge Corticium sp Novel abeo-9(10-19)-androstane-type steroidal alkaloids with isoquinoline unit, from marine sponge Corticium simplex angiogenic steroidal alkaloids, from the marine sponge Corticium simplex New cytotoxic steroidal alkaloids from the Philippine sponge Corticium niger Minor steroidal alkaloids from the marine sponge Corticium sp Plakinamines C and D and three other new steroidal alkaloids from the sponge Corticium sp Manadosterols A and B, sulfonated sterol dimers inhibiting the Ubc13-Uev1A interaction, isolated from the marine sponge Lissodendryx fibrosa Shishicrellastatins, inhibitors of cathepsin B, from the marine sponge Crella (Yvesia) spinulata Fibrosterol sulfates from the Philippine sponge Lissodendoryx (Acanthodoryx) fibrosa: sterol dimers that inhibit PKC Spheciosterol sulfates, PKCzeta inhibitors from a philippine sponge Spheciospongia sp Topsentiasterol sulfates with novel iodinated and chlorinated side chains from the marine sponge Topsentia sp A new cytotoxic cholesterol sulfate from marine sponge Halichondria rugosa Eurysterols A and B, cytotoxic and antifungal steroidal sulfates from a marine sponge of the genus Euryspongia A new sterol sulfate, Sch 572423, from a marine sponge, Topsentia sp Unusual polyoxygenated sterols from a Philippines sponge Xestospongia sp Crellastatin A: a cytotoxic bis-steroid sulfate from the Vanuatu marine sponge Crella sp Halistanol disulfate B, a novel sulfated sterol from the sponge Pachastrella sp.:inhibitor of endothelin converting enzyme Antiprotozoal steroidal saponins from the marine sponge Pandaros acanthifolium Eryloside F, a novel penasterol disaccharide possessing potent thrombin receptor antagonist activity Cinanthrenol A, an estrogenic steroid containing phenanthrene nucleus, from a marine sponge Cinachyrella sp New steroids with a rearranged skeleton as (h)P300 inhibitors from the sponge Theonella swinhoei Antifouling 26,27-cyclosterols from the Vietnamese marine sponge Xestospongia testudinaria Autophagymodulating aminosteroids isolated from the sponge Cliona celata Nakiterpiosin and Nakiterpiosinone, novel cytotoxic C-Nor-D-Homosteroids from the Okinawan sponge Terpios hoshinota A novel abeosterol inducing apoptosis in leukemia cell from a marine sponge, Stelletta hiwasaensis New 9,11-sSecosterol from the Tyrrhenian sponge Fasciospongia Cavernosa Aragusteroketals A and C, two novel cytotoxic steroids from a marine sponge of Xestospongia sp Xestobergsterol C, a new pentacyclic steroid from the Okinawan marine sponge Ircinia sp. and absolute stereochemistry of xestobergsterol A Aragusterol a: A potent antitumor marine steroid from the okinawan sponge of the genus, Xestospongia Aragusterol B and D, new 26,27-cyclosterols from the Okinawan marine sponge of the genus Xestospongia A novel halogenated marine steroid from an Okinawan sponge, Xestospongia sp., possessing potent antitumor activity A new bioactive steroidal ketone from the South China Sea sponge Xestospongiatestudinaria Antichlamydial sterol from the Red Sea sponge Callyspongia aff. implexa Novel cytotoxic polyoxygenated steroids from an Okinawan sponge Dysidea sp Topsentinols, 24-isopropyl steroids from the marine sponge Topsentia sp Norselic acids A-E, highly oxidized anti-infective steroids that deter mesograzer predation, from the Antarctic sponge Crella sp Steroids from an Australian sponge Psammoclema sp A series of new 5,6-epoxysterols from a Chinese sponge Ircinia aruensis Cytotoxic sterol derivatives from a marine sponge Homaxinella sp Polychlorinated androstanes from the burrowing sponge Cliona nigricans New cytotoxic steroids from the Indian Ocean sponge Axinella cf. bidderi Novel cytotoxic oxygenated C29 sterols from the Colombian marine sponge Polymastia tenax Gelliusterols A-D, new acetylenic sterols from a sponge, Gellius species Polyoxygenated dysidea sterols that inhibit the binding of [I 125] IL-8 to the human recombinant IL-8 receptor type A A new cytotoxic sterol methoxymethyl ether from a deep water marine sponge Scleritoderma sp. cf. paccardi Producing drugs from marine sponges Marine natural products Contributions to the study of marine products. XXXIX. The nucleosides of sponges. III. 1 Spongothymidine and spongouridine2 Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemia A highly cytotoxic tetrahydroisoquinoline alkaloid, from a marine sponge Neopetrosia sp Anticancer and antimetastatic activities of Renieramycin M, a marine tetrahydroisoquinoline alkaloid, in human non-small cell lung cancer cells Antibiotic and cytotoxic activity of brominated compounds from the marine sponge Verongia aerophoba Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cells Total synthesis of ageladine A, an angiogenesis inhibitor from the marine sponge Agelas nakamurai A one-pot synthesis and biological activity of ageladine A and analogues The alkaloid Ageladine A, originally isolated from marine sponges, used for pH-sensitive imaging of transparent marine animals Naamidine A is an antagonist of the epidermal growth factor receptor and an in vivo active antitumor agent The marine alkaloid naamidine A promotes caspase-dependent apoptosis in tumor cells Xestospongin B, a competitive inhibitor of IP3-mediated Ca2+ signalling in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108-15) cells Araguspongine C induces autophagic death in breast cancer cells through suppression of c-Met and HER2 receptor tyrosine kinase signaling The psammaplysenes, specific inhibitors of FOXO1a nuclear export Induction of apoptosis in endometrial cancer cells by psammaplysene A involves FOXO1 The marine sponge toxin agelasine B increases the intracellular Ca(2+) concentration and induces apoptosis in human breast cancer cells (MCF-7) Isolation and first total synthesis of PM050489 and PM060184, two new marine anticancer compounds New interfacial microtubule inhibitors of marine origin, PM050489/PM060184, with potent antitumor activity and a distinct mechanism PM060184, a new tubulin binding agent with potent antitumor activity including P-glycoprotein over-expressing tumors Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced nonsmall cell lung cancer previously treated with a taxane: a California cancer consortium trial A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-smallcell lung cancer 10-acetylirciformonin B, a sponge furanoterpenoid, induces DNA damage and apoptosis in leukemia cells Hyrtioreticulins A-E, indole alkaloids inhibiting the ubiquitin-activating enzyme, from the marine sponge Hyrtios reticulatus Ubiquitin binding by a CUE domain regulates ubiquitin chain formation by ERAD E3 ligases Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule-stabilizing activity Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells Peloruside A inhibits growth of human lung and breast tumor xenografts in an athymic nu/nu mouse model A new cytotoxic and tubulin-interactive milnamide derivative from a marine sponge Cymbastela sp Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin Phorbaketals A, B, and C, sesterterpenoids with a spiroketal of hydrobenzopyran moiety isolated from the marine sponge Phorbas sp Phorbaketal A, isolated from the marine sponge Phorbas sp., exerts its anti-inflammatory effects via NF-kappaB inhibition and heme oxygenase-1 activation in lipopolysaccharide-stimulated macrophages Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by epimuqubilin A via IKK/IkappaB/NF-kappaB pathways in lipopolysaccharide-stimulated RAW 264.7 cells Marine pyridoacridine alkaloids and synthetic analogues as antitumor agents Apoptosis signaling triggered by the marine alkaloid ascididemin is routed via caspase-2 and JNK to mitochondria Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP Investigation of the marine compound spongistatin 1 links the inhibition of PKCalpha translocation to nonmitotic effects of tubulin antagonism in angiogenesis